≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other and unspecified mononeuropathies of upper limb

DOID EFO Endpoint Browser PheWeb

G6_MONONPOTHUS

mononeuropathy: Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ischemia; traumatic injury; compression; connective tissue diseases; cumulative trauma disorders; and other conditions.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G56.8, G56.9
  • Hospital discharge: ICD-9 — 354[8-9]
  • Cause of death: ICD-10 — G56.8, G56.9
  • Cause of death: ICD-9 — 354[8-9]

2 out of 7 registries used, show all original rules.

1234

4. Check minimum number of events

None

1234

5. Include endpoints

None

1234

6. Filter based on genotype QC (FinnGen only)

1191

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8274 4003 4241
Only index persons 7776 3828 3948
Unadjusted period prevalence (%)
Whole population 0.12 0.11 0.12
Only index persons 0.15 0.14 0.15
Median age at first event (years)
Whole population 47.79 49.30 46.34
Only index persons 47.14 48.74 45.59

-FinnGen-

Key figures

All Female Male
Number of individuals 1191 647 544
Unadjusted period prevalence (%) 0.24 0.23 0.25
Median age at first event (years) 48.92 47.62 50.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1234
Matched controls
12340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G56.9
ICD-10 Finland
Mononeuropathy of upper limb, unspecified
1624.0
307.7
547
6
G56.0
ICD-10 Finland
Carpal tunnel syndrome
30.2
307.7
394
189
G56.8
ICD-10 Finland
Other mononeuropathies of upper limb
2534.3
307.7
558
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
318.6
236.4
233
9
G56.2
ICD-10 Finland
Lesion of ulnar nerve
46.8
219.5
130
31
ACC51
NOMESCO Finland
Release of median nerve
232.3
177.3
179
9
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
66.2
167.0
92
15
G54.0
ICD-10 Finland
Brachial plexus disorders
34.0
164.7
106
34
3548X
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Other mononeuritis of upper limb
+∞
143.6
135
*
N03AX16
ATC
[U] pregabalin
3.6
88.0
400
1463
N03AX12
ATC
[U] gabapentin; oral
3.9
81.5
291
901
XA402
NOMESCO Finland
ENMG
11.9
69.6
72
64
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.9
66.6
438
1945
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.7
65.9
132
256
M79.6
ICD-10 Finland
Pain in limb
2.7
64.2
681
3849
N02AX02
ATC
tramadol; systemic, rectal
2.7
61.8
637
3529
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
6.2
61.7
111
194
ACC53
NOMESCO Finland
Release of ulnar nerve
551.2
53.9
53
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.3
53.0
147
373
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
20.1
50.4
39
20
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.4
50.3
208
695
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
48.0
635
3808
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.5
47.2
123
297
N02BF01
ATC
gabapentin; oral
3.5
46.7
180
574
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.1
44.3
215
788
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.0
43.9
233
898
N06AX21
ATC
duloxetine; oral
3.1
43.7
206
742
M25.5
ICD-10 Finland
Pain in joint
2.3
40.3
502
2878
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
11.1
39.2
42
39
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
10.1
38.5
44
45
M47.9
ICD-10 Finland
Spondylosis, unspecified
6.2
35.8
63
107
M01AH05
ATC
etoricoxib; oral
2.2
34.6
849
6202
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
34.3
137
444
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.0
33.7
171
638
M54.5
ICD-10 Finland
Low back pain
2.1
33.6
511
3112
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.5
33.6
56
90
G57.6
ICD-10 Finland
Lesion of plantar nerve
12.0
33.5
34
29
R51.80
ICD-10 Finland
Headache
2.5
33.1
241
1081
G56.4
ICD-10 Finland
Causalgia
+∞
32.4
31
*
M50.3
ICD-10 Finland
Other cervical disc degeneration
6.7
32.2
52
81
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.5
32.0
115
348
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
31.7
132
438
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
30.8
491
3021
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.0
30.2
66
137
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
6.4
30.2
51
83
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
30.0
321
1694
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.9
29.8
154
579
X58
ICD-10 Finland
Exposure to other specified factors
2.4
29.4
239
1122
M01AB05
ATC
diclofenac; systemic, rectal
2.1
29.0
863
6546
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
5.2
28.7
60
120
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.9
28.7
52
91
M03BX02
ATC
tizanidine; oral
2.0
28.6
821
6133
M48.0
ICD-10 Finland
Spinal stenosis
2.8
28.4
156
605
R52.2
ICD-10 Finland
Other chronic pain
4.4
27.8
71
168
S18
ICPC
Laceration/cut
1.9
27.8
605
4103
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
27.2
254
1263
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
27.0
321
1757
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
27.0
572
3833
M02AA07
ATC
piroxicam; topical
2.0
27.0
447
2758
ZXA00
NOMESCO Finland
Right side
2.1
26.9
331
1834
ZXA05
NOMESCO Finland
Left side
2.1
25.7
307
1680
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
5.8
25.4
47
84
G56.3
ICD-10 Finland
Lesion of radial nerve
32.8
24.7
32
10
M77.1
ICD-10 Finland
Lateral epicondylitis
2.8
24.6
133
510
G44.2
ICD-10 Finland
Tension-type headache
2.4
24.2
196
913
H02AB06
ATC
prednisolone; systemic
1.8
24.2
592
4108
N06AA09
ATC
amitriptyline; systemic
2.8
24.0
128
487
A02BC01
ATC
omeprazole; systemic
2.0
23.6
334
1935
L12
ICPC
Hand/finger symptom/complaint
2.2
23.4
243
1254
A02BC02
ATC
pantoprazole; systemic
1.9
23.4
859
6731
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
23.4
123
465
M01AH01
ATC
celecoxib; oral
2.2
23.3
237
1213
M01AE03
ATC
ketoprofen; systemic, rectal
1.9
22.9
458
2970
N02BE01
ATC
paracetamol; systemic, rectal
2.6
22.7
1115
9659
G58.8
ICD-10 Finland
Other specified mononeuropathies
223.8
21.7
22
*
L08
ICPC
Shoulder symptom/complaint
2.0
21.6
307
1775
R03AC02
ATC
salbutamol; inhalant
1.8
20.9
689
5144
5851
FHL
Rib resection due to local change or compression
78.2
20.7
23
*
L03
ICPC
Low back symptom/complaint
1.9
20.7
366
2269
N02BF02
ATC
pregabalin; oral
2.9
20.3
99
359
M65.3
ICD-10 Finland
Trigger finger
3.6
20.1
69
202
M54.1
ICD-10 Finland
Radiculopathy
3.7
20.0
66
188
M01AE02
ATC
naproxen; oral, rectal
1.7
19.7
704
5337
ZXH06, ,
SPAT
3.0
19.6
88
304
A02BC03
ATC
lansoprazole; oral
1.9
19.6
349
2162
L01
ICPC
Neck symptom/complaint
2.1
19.6
219
1157
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.1
19.6
55
140
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
19.3
110
433
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
18.9
247
1379
R4120
NOMESCO Finland
Occupational therapy
2.8
18.9
97
361
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
4.4
18.9
47
109
M01AX17
ATC
nimesulide; oral
1.9
18.8
289
1705
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
8.2
18.8
25
31
M54.2
ICD-10 Finland
Cervicalgia
2.5
18.7
123
520
J01FF01
ATC
clindamycin; systemic
1.8
18.6
348
2183
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
18.4
146
672
M01AH02
ATC
rofecoxib; oral
2.3
18.2
155
734
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
18.0
125
541
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
53.3
18.0
21
*
SPAT1153
SPAT
Removal of sutures
1.8
17.8
358
2291
Z50.1
ICD-10 Finland
Other physical therapy
3.1
17.8
78
266
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
17.6
579
4244
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.2
17.5
36
71
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
17.3
101
402
R52.9
ICD-10 Finland
Pain, unspecified
2.3
17.2
145
683
N06AB04
ATC
citalopram; systemic
1.9
17.2
257
1499
A02BC05
ATC
esomeprazole; systemic
1.7
17.1
487
3428
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
17.1
345
2207
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
17.1
250
1447
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
16.9
288
1749
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
16.7
16
*
3549X
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Mononeuritis of upper limb, unspecified
+∞
16.7
16
*
SPAT1301
SPAT
No procedures
1.8
16.6
346
2232
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
16.5
346
2233
M89.0
ICD-10 Finland
Algoneurodystrophy
13.6
16.5
28
21
M54.3
ICD-10 Finland
Sciatica
2.8
16.4
82
301
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.4
16.2
119
528
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
16.1
124
562
J01DB01
ATC
cefalexin; oral
1.9
16.0
1015
8771
N03AE01
ATC
clonazepam; systemic
2.8
16.0
80
294
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.7
15.9
50
138
L11
ICPC
Wrist symptom/complaint
2.4
15.9
117
520
M70.6
ICD-10 Finland
Trochanteric bursitis
2.1
15.9
163
831
R06.0
ICD-10 Finland
Dyspnoea
1.8
15.9
319
2032
AA1AD
NOMESCO Finland
CT of head and brain
1.8
15.8
334
2159
3530A
ICD-9 Finland
Nerve root and plexus disorders, Brachial plexus lesions
+∞
15.7
15
*
M79.7
ICD-10 Finland
Fibromyalgia
3.4
15.5
55
165
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
4.2
15.4
41
100
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
5.6
15.3
29
53
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.8
15.3
77
284
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
18.0
15.2
23
13
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
15.1
164
853
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.6
15.1
89
356
M01AC06
ATC
meloxicam; systemic, rectal
1.7
15.0
426
2974
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
57.4
14.8
17
*
UJF32
NOMESCO Finland
Coloscopy
1.7
14.7
308
1980
9242
FHL
Other reconstruction or plastic surgery of shoulder joint (including ac joint)
6.4
14.6
24
38
J01DA01
ATC
[U] cefalexin
1.6
14.6
738
5918
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
14.5
184
1011
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
14.5
237
1415
A01
ICPC
Pain general/multiple sites
2.2
14.5
129
621
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
14.4
85
340
G50.1
ICD-10 Finland
Atypical facial pain
10.6
14.3
27
26
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.5
14.2
49
144
C07AB07
ATC
bisoprolol; oral
1.6
14.2
543
4066
M54.8
ICD-10 Finland
Other dorsalgia
2.9
14.0
67
240
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
13.9
258
1600
G56.1
ICD-10 Finland
Other lesions of median nerve
54.0
13.8
16
*
M79.1
ICD-10 Finland
Myalgia
1.9
13.8
195
1111
J01AA02
ATC
doxycycline; systemic
1.7
13.7
937
8027
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
13.7
172
940
J01MA02
ATC
ciprofloxacin; systemic
1.6
13.7
446
3203
R42
ICD-10 Finland
Dizziness and giddiness
1.8
13.7
265
1662
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
13.6
164
885
C03CA01
ATC
furosemide; systemic
1.7
13.4
297
1932
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
13.2
80
324
NBG10
NOMESCO Finland
Acromioplastia
4.0
13.2
37
94
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.7
13.1
338
2286
EB1VA, ,
NOMESCO Finland
1.8
13.1
232
1416
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
13.1
334
2255
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
5.1
12.9
27
54
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
12.9
52
169
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
4.6
12.9
30
66
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
12.8
351
2411
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
12.7
323
2174
M13.9
ICD-10 Finland
Arthritis, unspecified
2.3
12.7
96
431
L86
ICPC
Back syndrome with radiating pain
2.5
12.6
80
332
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
12.6
261
1665
R96
ICPC
Asthma
2.1
12.3
121
605
M24.2
ICD-10 Finland
Disorder of ligament
4.8
12.2
27
57
N03AF02
ATC
oxcarbazepine; oral
3.3
12.1
45
139
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.1
12.1
119
595
SFA10
NOMESCO Finland
One-surface restoration
1.5
12.1
663
5315
SPAT1310
SPAT
Counselling related to known health issue
1.6
12.1
342
2362
M75.8
ICD-10 Finland
Other shoulder lesions
2.8
12.1
60
220
R02
ICPC
Shortness of breath/dyspnoea
1.9
11.8
156
866
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.3
11.8
30
71
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
11.8
264
1717
7261X
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]
9.7
11.8
23
24
N03AX09
ATC
lamotrigine; oral
2.6
11.7
68
270
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.4
11.7
83
363
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.3
11.7
94
434
ZYC01, ,
SPAT
2.0
11.7
136
724
SFA30
NOMESCO Finland
Three-surface restoration
1.5
11.6
522
3997
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.2
11.6
30
72
M01AE01
ATC
ibuprofen; systemic, rectal
2.0
11.6
1111
10134
R01AD09
ATC
mometasone; nasal
1.5
11.5
541
4180
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
11.3
53
188
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
11.3
867
7424
SPAT1260
SPAT
Consultation of another employee
1.8
11.3
188
1124
M03BX01
ATC
baclofen; systemic
4.1
11.2
31
78
SPAT1263
SPAT
Sampling
1.5
11.2
452
3373
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.5
11.2
69
282
WZC30
NOMESCO Finland
Teaching
1.8
11.2
201
1228
M01AH03
ATC
valdecoxib; oral
2.4
11.1
75
320
R07.3
ICD-10 Finland
Other chest pain
2.0
11.1
131
700
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.8
11.1
33
88
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
11.0
296
2012
S06.0
ICD-10 Finland
Concussion
2.0
11.0
134
724
M77.0
ICD-10 Finland
Medial epicondylitis
3.1
11.0
45
148
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
11.0
511
3930
N05AH04
ATC
quetiapine; oral
1.7
10.9
213
1331
N06AA10
ATC
nortriptyline; systemic
3.8
10.9
33
89
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.5
10.9
67
274
K08.80
ICD-10 Finland
Toothache NOS
2.0
10.9
118
612
N05BA04
ATC
oxazepam; oral
1.6
10.9
298
2034
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
10.8
231
1479
TAB00
NOMESCO Finland
Lumbar puncture
2.6
10.7
61
240
L02
ICPC
Back symptom/complaint
1.9
10.7
133
723
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
10.7
87
403
N02AA05
ATC
oxycodone; systemic
1.8
10.7
190
1157
N06AX11
ATC
mirtazapine; oral
1.5
10.7
389
2835
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.6
10.7
60
235
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.4
10.6
72
308
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
3.5
10.6
36
105
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
10.6
134
733
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.3
10.6
40
125
N01
ICPC
Headache
1.9
10.6
132
719
WX702
NOMESCO Finland
Supraglottic ventilation device
2.4
10.6
75
328
A02BA02
ATC
ranitidine; systemic
1.7
10.6
204
1271
G50.0
ICD-10 Finland
Trigeminal neuralgia
10.1
10.5
20
20
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
10.5
120
634
K02.1
ICD-10 Finland
Caries of dentine
1.5
10.5
706
5832
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.2
10.5
40
126
3542A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve
+∞
10.4
10
*
ACC52
NOMESCO Finland
Release of radial nerve
+∞
10.4
10
*
WX704
NOMESCO Finland
Intubation
2.1
10.3
95
463
R06AE07
ATC
cetirizine; oral
1.5
10.3
505
3909
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
10.3
530
4143
A46
ICD-10 Finland
Erysipelas
1.8
10.3
166
981
J01CA04
ATC
amoxicillin; systemic
1.6
10.3
971
8602
G51.0
ICD-10 Finland
Bell palsy
19.0
10.3
15
8
L28
ICPC
Limited function/disability (L)
1.7
10.3
193
1193
NCL99
NOMESCO Finland
Other operation on muscle or tendon of elbow or forearm
13.2
10.2
17
13
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
10.2
453
3438
N06AX16
ATC
venlafaxine; oral
1.8
10.1
171
1024
Z71.8
ICD-10 Finland
Other specified counselling
1.5
10.1
402
2977
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
10.1
849
7313
WX200
NOMESCO Finland
Interscalenous plexus blockade
3.5
10.1
34
99
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
3.0
10.0
45
156
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.9
9.9
136
764
M54.6
ICD-10 Finland
Pain in thoracic spine
2.1
9.9
98
491
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.8
9.9
50
185
WZC00, ,
SPAT
1.8
9.9
174
1054
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
9.9
291
2014
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
3.8
9.9
30
81
M01AX05
ATC
glucosamine; oral
1.7
9.9
188
1165
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.9
9.8
134
752
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
9.6
9.8
19
20
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.9
9.7
137
776
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
3.0
9.6
41
138
N03AF01
ATC
carbamazepine; oral, rectal
2.6
9.6
57
229
R03DC03
ATC
montelukast; oral
1.7
9.6
191
1197
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
2.9
9.6
45
160
J01FA06
ATC
roxithromycin; oral
1.5
9.6
445
3394
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
9.6
242
1614
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
2.5
9.6
58
236
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
4.6
9.6
22
48
G43.9
ICD-10 Finland
Migraine, unspecified
2.2
9.5
76
350
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.5
204
1307
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
9.4
789
6737
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
9.4
336
2426
S22.3
ICD-10 Finland
Fracture of rib
2.1
9.4
95
480
2401
FHL
Nerve exploration (includes biopsy and removal of local change)
30.3
9.4
12
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.8
9.4
28
75
T92.4
ICD-10 Finland
Sequelae of injury of nerve of upper limb
21.9
9.4
13
6
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.1
9.4
88
433
M35.7
ICD-10 Finland
Hypermobility syndrome
4.7
9.3
21
45
S43.0
ICD-10 Finland
Dislocation of shoulder joint
2.6
9.2
51
198
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
9.2
80
381
G04CA02
ATC
tamsulosin; oral
1.6
9.2
230
1528
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
3.5
9.2
31
90
WX204
NOMESCO Finland
Axillary plexus blockaced
2.7
9.2
48
181
C07AA05
ATC
propranolol; systemic
1.6
9.2
236
1579
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.9
9.2
116
635
M25.2
ICD-10 Finland
Flail joint
5.1
9.1
19
38
R03BA05
ATC
fluticasone; inhalant
1.7
9.1
200
1287
SFA20
NOMESCO Finland
Two-surface restoration
1.4
9.1
700
5864
M01AB55
ATC
diclofenac, combinations; oral
2.2
9.1
74
344
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.6
9.1
52
206
D07AC01
ATC
betamethasone; topical
1.5
9.0
402
3034
N17
ICPC
Vertigo/dizziness
1.8
9.0
141
825
M22.4
ICD-10 Finland
Chondromalacia patellae
2.9
9.0
41
144
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
9.0
279
1952
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
8.9
223
1482
SPAT1240
SPAT
Therapeutic discussion
1.9
8.9
119
663
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
8.9
642
5306
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
8.9
338
2470
J01EA01
ATC
trimethoprim; systemic
1.6
8.9
261
1803
H02AB04
ATC
methylprednisolone; systemic
1.7
8.8
161
986
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
8.8
76
362
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.8
8.8
43
157
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
8.8
411
3130
IGY02, ,
SPAT
3.7
8.7
27
74
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.1
8.7
83
410
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.7
106
572
SPAT1254
SPAT
Administration of medicine
1.8
8.7
141
834
G57.9
ICD-10 Finland
Mononeuropathy of lower limb, unspecified
50.3
8.7
10
*
G56
ICD-10 Finland
Mononeuropathies of upper limb
50.3
8.7
10
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.3
8.6
62
273
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
8.6
90
461
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.8
8.6
43
159
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
8.6
140
830
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
16.4
8.6
13
8
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
8.6
112
620
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.3
8.5
61
268
R52.1
ICD-10 Finland
Chronic intractable pain
9.1
8.5
17
19
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.9
8.5
107
584
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
8.5
147
886
L16
ICPC
Ankle symptom/complaint
1.8
8.5
138
817
G58.9
ICD-10 Finland
Mononeuropathy, unspecified
20.2
8.5
12
6
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
8.5
88
450
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
3.1
8.4
34
111
C10AC01
ATC
colestyramine; oral
3.0
8.4
37
127
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
8.4
103
557
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
4.7
8.4
19
41
R60.0
ICD-10 Finland
Localized oedema
1.8
8.4
134
790
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
8.3
8
*
GAE40
NOMESCO Finland
Operation on rib and soft tissues for thoracic outlet syndrome
+∞
8.3
8
*
L09
ICPC
Arm symptom/complaint
2.3
8.3
61
271
C01DA14
ATC
isosorbide mononitrate; oral
1.8
8.3
131
768
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.7
8.3
26
72
R03BA01
ATC
beclometasone; inhalant
1.7
8.3
146
884
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.3
460
3609
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
3.3
8.2
30
92
SGA01
NOMESCO Finland
Emergency treatment
1.6
8.2
197
1294
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
8.2
161
1004
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
8.2
229
1560
M75.2
ICD-10 Finland
Bicipital tendinitis
3.1
8.2
34
113
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
8.2
91
477
E0000UV, ,
ATC
1.4
8.2
465
3663
WW200, ,
SPAT
1.5
8.1
346
2578
EC1VA, ,
NOMESCO Finland
2.3
8.1
63
287
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
8.1
86
443
R1430, ,
SPAT
4.1
8.1
22
55
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.8
8.1
40
147
L17
ICPC
Foot/toe symptom/complaint
1.5
8.0
332
2460
M75.5
ICD-10 Finland
Bursitis of shoulder
3.1
8.0
32
104
N05CF01
ATC
zopiclone; oral
1.5
8.0
336
2497
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.7
8.0
139
839
M01AC01
ATC
piroxicam; systemic, rectal
1.7
8.0
137
824
R51
ICD-10 Finland
Headache
2.2
8.0
69
329
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
7.9
102
561
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.3
7.9
61
277
C02AC05
ATC
moxonidine; oral
2.4
7.9
52
220
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
7.9
247
1725
T92.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of upper limb
6.6
7.9
19
29
M43.1
ICD-10 Finland
Spondylolisthesis
2.6
7.9
46
184
A02BA04
ATC
nizatidine; systemic
2.1
7.9
78
392
EBA00
NOMESCO Finland
Extraction of tooth
1.4
7.9
412
3191
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.3
7.8
28
85
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
7.8
49
203
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
7.8
152
946
R63.4
ICD-10 Finland
Abnormal weight loss
2.5
7.8
47
191
L20
ICPC
Joint symptom/complaint NOS
2.5
7.8
46
185
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
7.8
202
1352
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
9.5
7.8
15
16
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
7.8
198
1319
OAB42, ,
SPAT
1.7
7.8
153
955
WX720
NOMESCO Finland
Own respiration
2.3
7.8
58
260
S83.2
ICD-10 Finland
Tear of meniscus, current
2.0
7.8
87
457
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.0
7.8
79
401
L13
ICPC
Hip symptom/complaint
1.6
7.7
200
1337
B01AB05
ATC
enoxaparin; parenteral
1.5
7.7
330
2457
J01FA09
ATC
clarithromycin; systemic
1.5
7.7
348
2618
G55.2
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
15.1
7.7
12
8
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.4
7.7
27
81
L92
ICPC
Shoulder syndrome
3.0
7.7
32
107
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.0
7.7
32
107
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.7
284
2056
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.0
7.6
21
53
J46
ICD-10 Finland
Status asthmaticus
2.9
7.6
34
118
D01
ICPC
Abdominal pain/cramps general
1.7
7.6
135
819
ZXA10
NOMESCO Finland
Bilateral
1.6
7.6
181
1186
K10.3
ICD-10 Finland
Alveolitis of jaws
2.2
7.6
61
282
R01AD58
ATC
fluticasone, combinations; nasal
1.5
7.6
285
2067
J01FA10
ATC
azithromycin; systemic
1.4
7.6
656
5533
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
11.9
7.6
13
11
ZXD05
NOMESCO Finland
Urgent procedure
1.5
7.6
323
2404
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
7.6
259
1844
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
6.2
7.6
19
31
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
3.4
7.5
26
77
H01
ICPC
Ear pain/earache
1.8
7.5
126
752
SPAT1255
SPAT
Intravenous administration of medicine
2.1
7.5
69
337
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.5
275
1985
Y96.0
ICD-10 Finland
Work-related condition
4.3
7.5
19
45
C08CA05
ATC
nifedipine; systemic
2.3
7.5
57
258
T15.0
ICD-10 Finland
Foreign body in cornea
2.5
7.5
45
183
ZXD20
NOMESCO Finland
Day surgery
1.7
7.5
135
824
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
7.7
7.4
16
21
S14.3
ICD-10 Finland
Injury of brachial plexus
13.4
7.4
12
9
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.9
7.4
33
115
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
7.4
130
788
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.3
202
1370
C10AA01
ATC
simvastatin; oral
1.4
7.3
396
3077
T92.2
ICD-10 Finland
Sequelae of fracture at wrist and hand level
6.9
7.3
17
25
G54.5
ICD-10 Finland
Neuralgic amyotrophy
+∞
7.3
7
*
35399
ICD-8 Finland
Sciatica
+∞
7.3
7
*
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
3.3
7.3
27
84
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.3
580
4814
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.3
7.2
18
42
S21
ICPC
Skin texture symptom/complaint
1.6
7.2
161
1038
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.2
594
4954
A03
ICPC
Fever
1.6
7.2
188
1259
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
7.2
98
550
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
4.0
7.2
20
51
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.0
7.2
20
51
S63.3
ICD-10 Finland
Traumatic rupture of ligament of wrist and carpus
3.6
7.2
23
65
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.5
7.2
257
1846
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.1
7.1
67
330
D07AD01
ATC
clobetasol; topical
1.6
7.1
186
1245
9502
FHL
Tendon splitting (De Quervain, click finger)
20.1
7.1
10
5
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.1
276
2012
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
3.4
7.1
25
75
A08
ICPC
Swelling
2.1
7.1
66
324
G47.3
ICD-10 Finland
Sleep apnoea
1.5
7.1
269
1953
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
7.0
97
546
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
7.0
62
298
C10AA05
ATC
atorvastatin; oral
1.4
7.0
445
3548
R03BA02
ATC
budesonide; inhalant
1.6
7.0
197
1342
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
7.0
63
306
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
7.0
273
1995
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.9
651
5532
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
6.9
80
425
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
6.9
83
447
NC1BG
NOMESCO Finland
Elbow MRI examination with high intensity magnet
7.6
6.9
15
20
M01AE51
ATC
ibuprofen, combinations; systemic
4.0
6.9
19
48
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.9
125
763
R21
ICPC
Throat symptom/complaint
1.5
6.9
227
1600
C09CA06
ATC
candesartan; oral
1.5
6.9
273
2000
A01AB09
ATC
miconazole; local oral
1.9
6.8
85
463
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
6.8
102
589
NBE45
NOMESCO Finland
Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic
4.1
6.8
18
44
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.8
6.8
20
53
N93
ICPC
Carpal tunnel syndrome
6.7
6.8
16
24
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.2
6.8
54
249
7233A
ICD-9 Finland
Other disorders of cervical region, Cervicobrachial syndrome (diffuse)
11.0
6.8
12
11
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
6.8
57
269
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
6.8
144
917
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.3
6.8
48
211
R4110
NOMESCO Finland
Physiotherapy
1.4
6.8
296
2208
SGB20
NOMESCO Finland
Root filling of tooth with onetwo root canals
1.9
6.8
80
429
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.7
146
934
R5599
NOMESCO Finland
Other rehabilitation service
2.8
6.7
33
121
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
3.5
6.7
22
63
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.0
6.7
76
401
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.7
184
1246
D11
ICPC
Diarrhoea
1.7
6.7
131
817
AB6CG
NOMESCO Finland
Extensive MRI of brachial plexus
22.6
6.7
9
*
TAD02
NOMESCO Finland
Sympathetic block of ganglion stellatum
22.6
6.7
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
6.7
371
2888
N02AC04
ATC
dextropropoxyphene; oral
2.6
6.7
36
139
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.1
6.7
61
298
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
6.6
53
245
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
2.8
6.6
33
122
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
6.6
66
333
N06AX22
ATC
agomelatine; oral
2.8
6.6
31
111
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
2.6
6.6
36
140
A03FA02
ATC
cisapride; oral, rectal
2.0
6.6
69
355
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
6.6
45
195
M50.9
ICD-10 Finland
Cervical disc disorder, unspecified
6.9
6.5
15
22
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
6.5
341
2625
SFA00
NOMESCO Finland
Small restoration
1.6
6.5
156
1024
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
5.4
6.5
18
34
C07AB04
ATC
acebutolol; systemic
4.0
6.4
18
46
C08CA01
ATC
amlodipine; oral
1.4
6.4
391
3086
R05
ICPC
Cough
1.5
6.4
264
1943
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.4
6.4
22
65
N04BC05
ATC
pramipexole; oral
1.9
6.4
78
422
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.6
6.4
35
136
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
6.4
77
416
AN1
HP
Coronary angiography
1.8
6.4
97
564
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
6.3
132
836
SPAT1216
SPAT
Assessment of functional ability
1.6
6.3
140
900
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
8.2
6.3
13
16
A10AE04
ATC
insulin glargine; parenteral
1.8
6.3
96
557
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
6.3
95
550
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
5.5
6.3
17
31
WZB00, ,
SPAT
1.8
6.3
94
543
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.3
6.3
23
71
WZC30, ,
SPAT
1.8
6.3
97
566
TQW40, ,
SPAT
1.7
6.3
118
728
J45
ICD-10 Finland
Asthma
1.7
6.3
111
674
R13
ICD-10 Finland
Dysphagia
1.9
6.3
74
397
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.2
118
729
IHZ04, ,
SPAT
3.1
6.2
25
82
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.2
250
1833
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
6.2
57
280
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
6.1
30
110
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.7
6.1
120
749
S29
ICPC
Skin symptom/complaint other
1.5
6.1
212
1509
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
6.1
48
221
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
4.1
6.1
16
39
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.1
6.1
16
39
R05
ICD-10 Finland
Cough
1.5
6.1
230
1665
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
12.6
6.1
10
8
J98.6
ICD-10 Finland
Disorders of diaphragm
12.6
6.1
10
8
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
12.6
6.1
10
8
A29
ICPC
General symptom/complaint other
1.6
6.1
142
926
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.0
6.1
62
316
C10AX09
ATC
ezetimibe; oral
1.5
6.1
184
1273
N05BA01
ATC
diazepam; systemic, rectal
1.6
6.1
138
894
L30.3
ICD-10 Finland
Infective dermatitis
2.3
6.0
44
196
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
3.3
6.0
22
68
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
3.3
6.0
22
68
L14
ICPC
Leg/thigh symptom/complaint
1.8
6.0
87
498
R55
ICD-10 Finland
Syncope and collapse
1.7
6.0
109
666

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hand Surgery
40 [38004480]
1.6e+00
2.6e+00
3.1e+00
1.0e+50
4.3e+00
3.5e+00
2.0e+00
cases:6.45%
controls:1.40%
cases:6.03%
controls:0.50%
cases:1.93%
controls:0.08%
cases:13.40%
controls:0.00%
cases:4.61%
controls:0.07%
cases:15.37%
controls:0.56%
cases:12.05%
controls:1.77%
77
166
1117
11727
72
59
1122
11834
23
10
1171
11883
160
0
1034
11893
55
8
1139
11869
180
65
991
11613
130
188
949
10448
Physical Medicine And Rehabilitation
25 [38004468]
1.3e+00
2.3e+00
2.4e+00
—
3.1e+00
2.8e+00
1.5e+00
cases:13.57%
controls:3.94%
cases:11.81%
controls:1.33%
cases:3.27%
controls:0.29%
—
—
cases:5.86%
controls:0.29%
cases:21.09%
controls:1.64%
cases:18.91%
controls:4.78%
162
468
1032
11425
141
158
1053
11735
39
35
1155
11858
—
70
34
1124
11843
247
191
924
11487
204
508
875
10128
Outpatient Visit
OP [9202]
7.7e-01
1.0e+00
1.1e+00
6.5e+00
1.5e+00
1.4e+00
8.0e-01
cases:73.12%
controls:55.72%
cases:59.88%
controls:35.35%
cases:19.35%
controls:7.13%
cases:64.66%
controls:0.27%
cases:26.55%
controls:7.32%
cases:69.00%
controls:35.72%
cases:80.07%
controls:64.26%
873
6627
321
5266
715
4204
479
7689
231
848
963
11045
772
32
422
11861
317
869
877
11008
808
4171
363
7507
864
6835
215
3801
gabapentin; oral
N02BF01 [955005]
1.6e+00
2.2e+00
2.5e+00
—
2.6e+00
2.5e+00
1.7e+00
cases:5.11%
controls:1.08%
cases:5.19%
controls:0.61%
cases:1.68%
controls:0.14%
—
—
cases:2.51%
controls:0.19%
cases:7.17%
controls:0.63%
cases:8.90%
controls:1.75%
61
129
1133
11764
62
72
1132
11821
20
17
1174
11876
—
30
22
1164
11855
84
74
1087
11604
96
186
983
10450
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
2.2e+00
2.4e+00
—
1.0e+50
3.5e+00
2.8e+00
2.2e+00
cases:2.85%
controls:0.33%
cases:1.59%
controls:0.15%
—
—
cases:2.18%
controls:0.00%
cases:1.84%
controls:0.06%
cases:2.90%
controls:0.19%
cases:3.80%
controls:0.44%
34
39
1160
11854
19
18
1175
11875
—
26
0
1168
11893
22
7
1172
11870
34
22
1137
11656
41
47
1038
10589
Neurosurgery
14 [38004459]
1.3e+00
1.9e+00
2.8e+00
1.0e+50
2.6e+00
2.7e+00
1.5e+00
cases:4.69%
controls:1.32%
cases:3.60%
controls:0.53%
cases:1.17%
controls:0.08%
cases:1.93%
controls:0.00%
cases:1.01%
controls:0.08%
cases:6.32%
controls:0.47%
cases:6.30%
controls:1.41%
56
157
1138
11736
43
63
1151
11830
14
9
1180
11884
23
0
1171
11893
12
9
1182
11868
74
55
1097
11623
68
150
1011
10486
Carpal tunnel syndrome
G56.0 [45566891]
3.8e+00
5.2e+00
1.0e+50
1.0e+50
—
—
3.6e+00
cases:5.36%
controls:0.13%
cases:8.12%
controls:0.05%
cases:3.02%
controls:0.00%
cases:2.35%
controls:0.00%
—
—
—
—
cases:7.88%
controls:0.23%
64
15
1130
11878
97
6
1097
11887
36
0
1158
11893
28
0
1166
11893
—
—
85
24
994
10612
Shoulder symptom/complaint
L08 [2002000632]
8.7e-01
1.9e+00
3.0e+00
—
3.2e+00
1.6e+00
9.7e-01
cases:3.18%
controls:1.36%
cases:3.35%
controls:0.50%
cases:0.84%
controls:0.04%
—
—
cases:1.01%
controls:0.04%
cases:2.73%
controls:0.57%
cases:5.38%
controls:2.12%
38
162
1156
11731
40
59
1154
11834
10
5
1184
11888
—
12
5
1182
11872
32
66
1139
11612
58
225
1021
10411
pregabalin; oral
N02BF02 [955152]
1.3e+00
1.9e+00
1.9e+00
—
2.3e+00
1.8e+00
1.4e+00
cases:6.78%
controls:1.98%
cases:6.45%
controls:1.02%
cases:1.93%
controls:0.29%
—
—
cases:2.68%
controls:0.27%
cases:6.06%
controls:1.05%
cases:9.08%
controls:2.37%
81
235
1113
11658
77
121
1117
11772
23
34
1171
11859
—
32
32
1162
11845
71
123
1100
11555
98
252
981
10384
Inpatient Hospital
21 [8717]
6.4e-01
9.7e-01
8.5e-01
4.9e+00
1.3e+00
9.9e-01
6.7e-01
cases:38.94%
controls:25.23%
cases:19.18%
controls:8.25%
cases:2.51%
controls:1.08%
cases:8.29%
controls:0.07%
cases:3.60%
controls:0.99%
cases:18.19%
controls:7.66%
cases:35.50%
controls:22.04%
465
3001
729
8892
229
981
965
10912
30
129
1164
11764
99
8
1095
11885
43
117
1151
11760
213
894
958
10784
383
2344
696
8292
Physiotherapist
Z3226 [2001311560]
9.4e-01
1.6e+00
2.1e+00
—
2.4e+00
2.1e+00
8.6e-01
cases:3.52%
controls:1.40%
cases:2.35%
controls:0.49%
cases:0.75%
controls:0.09%
—
—
cases:1.26%
controls:0.12%
cases:3.50%
controls:0.45%
cases:3.06%
controls:1.32%
42
167
1152
11726
28
58
1166
11835
9
11
1185
11882
—
15
14
1179
11863
41
52
1130
11626
33
140
1046
10496
Orthopedic Surgery
20 [38004465]
1.0e+00
1.4e+00
1.8e+00
—
2.6e+00
2.0e+00
1.1e+00
cases:21.19%
controls:8.83%
cases:13.40%
controls:3.77%
cases:3.35%
controls:0.59%
—
—
cases:6.53%
controls:0.51%
cases:19.81%
controls:3.39%
cases:27.15%
controls:11.54%
253
1050
941
10843
160
448
1034
11445
40
70
1154
11823
—
78
61
1116
11816
232
396
939
11282
293
1227
786
9409
Other specified special examinations
Z01.8 [45581003]
8.7e-01
1.3e+00
2.4e+00
—
2.8e+00
1.4e+00
1.0e+00
cases:3.94%
controls:1.68%
cases:1.68%
controls:0.47%
cases:0.92%
controls:0.08%
—
—
cases:0.92%
controls:0.06%
cases:1.96%
controls:0.48%
cases:5.38%
controls:1.99%
47
200
1147
11693
20
56
1174
11837
11
10
1183
11883
—
11
7
1183
11870
23
56
1148
11622
58
212
1021
10424
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.9e+00
2.7e+00
1.0e+50
1.0e+50
—
3.3e+00
1.8e+00
cases:1.51%
controls:0.24%
cases:1.26%
controls:0.08%
cases:0.50%
controls:0.00%
cases:1.26%
controls:0.00%
—
—
cases:1.54%
controls:0.06%
cases:1.67%
controls:0.27%
18
28
1176
11865
15
10
1179
11883
6
0
1188
11893
15
0
1179
11893
—
18
7
1153
11671
18
29
1061
10607
Cervical disc disorder with radiculopathy
M50.1 [45596588]
1.2e+00
3.1e+00
—
—
—
3.9e+00
2.4e+00
cases:0.75%
controls:0.24%
cases:1.51%
controls:0.07%
—
—
—
—
—
—
cases:2.90%
controls:0.06%
cases:2.13%
controls:0.19%
9
28
1185
11865
18
8
1176
11885
—
—
—
34
7
1137
11671
23
20
1056
10616
Neurology
13 [38004458]
9.2e-01
1.5e+00
1.9e+00
—
2.1e+00
1.8e+00
1.3e+00
cases:15.33%
controls:6.75%
cases:11.31%
controls:2.67%
cases:3.77%
controls:0.60%
—
—
cases:4.61%
controls:0.59%
cases:15.46%
controls:3.02%
cases:21.78%
controls:7.37%
183
803
1011
11090
135
318
1059
11575
45
71
1149
11822
—
55
70
1139
11807
181
353
990
11325
235
784
844
9852
Paraesthesia of skin
R20.2 [45568120]
1.3e+00
2.3e+00
—
—
2.1e+00
2.0e+00
1.5e+00
cases:1.59%
controls:0.43%
cases:1.59%
controls:0.16%
—
—
—
—
cases:0.50%
controls:0.06%
cases:1.20%
controls:0.16%
cases:2.22%
controls:0.52%
19
51
1175
11842
19
19
1175
11874
—
—
6
7
1188
11870
14
19
1157
11659
24
55
1055
10581
Physiotherapy
R4110 [2001310233]
8.4e-01
1.3e+00
1.9e+00
—
2.1e+00
1.9e+00
1.1e+00
cases:5.53%
controls:2.46%
cases:3.94%
controls:1.08%
cases:1.26%
controls:0.18%
—
—
cases:1.59%
controls:0.19%
cases:6.23%
controls:0.97%
cases:7.23%
controls:2.53%
66
292
1128
11601
47
128
1147
11765
15
22
1179
11871
—
19
23
1175
11854
73
113
1098
11565
78
269
1001
10367
Pain in limb
M79.6 [45587063]
8.9e-01
1.7e+00
2.0e+00
—
2.3e+00
1.3e+00
1.1e+00
cases:7.79%
controls:3.35%
cases:7.04%
controls:1.37%
cases:1.26%
controls:0.17%
—
—
cases:1.42%
controls:0.15%
cases:4.70%
controls:1.37%
cases:14.09%
controls:5.23%
93
399
1101
11494
84
163
1110
11730
15
20
1179
11873
—
17
18
1177
11859
55
160
1116
11518
152
556
927
10080
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.1e+00
1.7e+00
1.5e+00
—
2.1e+00
1.7e+00
1.0e+00
cases:13.82%
controls:4.99%
cases:10.22%
controls:1.95%
cases:1.59%
controls:0.36%
—
—
cases:2.93%
controls:0.37%
cases:9.22%
controls:1.76%
cases:14.55%
controls:5.86%
165
594
1029
11299
122
232
1072
11661
19
43
1175
11850
—
35
44
1159
11833
108
206
1063
11472
157
623
922
10013
General Surgery
2 [38004447]
9.9e-01
1.4e+00
1.9e+00
—
2.3e+00
1.7e+00
9.2e-01
cases:34.84%
controls:16.55%
cases:19.77%
controls:5.71%
cases:4.52%
controls:0.70%
—
—
cases:5.78%
controls:0.63%
cases:20.58%
controls:4.70%
cases:30.12%
controls:14.60%
416
1968
778
9925
236
679
958
11214
54
83
1140
11810
—
69
75
1125
11802
241
549
930
11129
325
1553
754
9083
Rheumatism, unspecified
M79.0 [45567658]
2.0e+00
2.6e+00
—
—
—
2.1e+00
2.4e+00
cases:1.01%
controls:0.13%
cases:0.67%
controls:0.05%
—
—
—
—
—
—
cases:0.60%
controls:0.08%
cases:1.20%
controls:0.11%
12
16
1182
11877
8
6
1186
11887
—
—
—
7
9
1164
11669
13
12
1066
10624
Other spondylosis with radiculopathy
M47.2 [45591850]
1.6e+00
1.9e+00
—
1.0e+50
—
3.2e+00
2.2e+00
cases:1.34%
controls:0.26%
cases:1.17%
controls:0.18%
—
—
cases:0.42%
controls:0.00%
—
—
cases:2.13%
controls:0.09%
cases:3.06%
controls:0.34%
16
31
1178
11862
14
21
1180
11872
—
5
0
1189
11893
—
25
10
1146
11668
33
36
1046
10600
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.3e+00
2.2e+00
1.9e+00
—
1.9e+00
1.7e+00
1.8e+00
cases:1.76%
controls:0.48%
cases:2.18%
controls:0.24%
cases:0.50%
controls:0.08%
—
—
cases:0.92%
controls:0.14%
cases:2.05%
controls:0.37%
cases:4.54%
controls:0.80%
21
57
1173
11836
26
29
1168
11864
6
9
1188
11884
—
11
17
1183
11860
24
43
1147
11635
49
85
1030
10551
Rotator cuff syndrome
M75.1 [45596678]
1.1e+00
1.8e+00
2.8e+00
—
—
1.8e+00
1.1e+00
cases:5.36%
controls:1.89%
cases:4.02%
controls:0.66%
cases:1.01%
controls:0.06%
—
—
—
—
cases:4.87%
controls:0.80%
cases:8.16%
controls:2.93%
64
225
1130
11668
48
78
1146
11815
12
7
1182
11886
—
—
57
94
1114
11584
88
312
991
10324
Occupational therapy
R4120 [2001310234]
1.4e+00
2.2e+00
—
—
—
2.9e+00
1.7e+00
cases:1.34%
controls:0.34%
cases:0.75%
controls:0.08%
—
—
—
—
—
—
cases:2.05%
controls:0.11%
cases:2.04%
controls:0.38%
16
41
1178
11852
9
10
1185
11883
—
—
—
24
13
1147
11665
22
40
1057
10596
Impingement syndrome of shoulder
M75.4 [45553266]
1.3e+00
2.0e+00
—
1.0e+50
—
3.3e+00
1.5e+00
cases:1.68%
controls:0.47%
cases:1.42%
controls:0.19%
—
—
cases:0.92%
controls:0.00%
—
—
cases:1.79%
controls:0.07%
cases:2.69%
controls:0.60%
20
56
1174
11837
17
23
1177
11870
—
11
0
1183
11893
—
21
8
1150
11670
29
64
1050
10572
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
8.4e-01
2.2e+00
2.3e+00
1.0e+50
—
2.3e+00
1.2e+00
cases:0.75%
controls:0.33%
cases:1.17%
controls:0.13%
cases:0.50%
controls:0.05%
cases:0.42%
controls:0.00%
—
—
cases:1.37%
controls:0.14%
cases:1.58%
controls:0.50%
9
39
1185
11854
14
15
1180
11878
6
6
1188
11887
5
0
1189
11893
—
16
16
1155
11662
17
53
1062
10583
Exposure to unspecified factor
X59 [45756412]
9.7e-01
1.7e+00
1.5e+00
1.0e+50
2.5e+00
1.8e+00
9.8e-01
cases:3.77%
controls:1.46%
cases:2.18%
controls:0.39%
cases:0.42%
controls:0.09%
cases:0.67%
controls:0.00%
cases:0.59%
controls:0.05%
cases:2.48%
controls:0.42%
cases:4.63%
controls:1.80%
45
174
1149
11719
26
46
1168
11847
5
11
1189
11882
8
0
1186
11893
7
6
1187
11871
29
49
1142
11629
50
191
1029
10445
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
7.1e-01
1.2e+00
2.4e+00
1.0e+50
1.9e+00
9.0e-01
8.4e-01
cases:5.03%
controls:2.55%
cases:2.68%
controls:0.86%
cases:0.92%
controls:0.08%
cases:1.01%
controls:0.00%
cases:0.75%
controls:0.12%
cases:2.31%
controls:0.95%
cases:7.78%
controls:3.53%
60
303
1134
11590
32
102
1162
11791
11
10
1183
11883
12
0
1182
11893
9
14
1185
11863
27
111
1144
11567
84
375
995
10261
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
6.8e-01
8.6e-01
7.3e-01
2.7e+00
1.2e+00
8.8e-01
7.0e-01
cases:33.08%
controls:20.10%
cases:21.52%
controls:10.37%
cases:2.93%
controls:1.43%
cases:0.84%
controls:0.06%
cases:4.77%
controls:1.51%
cases:22.20%
controls:10.55%
cases:41.98%
controls:26.48%
395
2391
799
9502
257
1233
937
10660
35
170
1159
11723
10
7
1184
11886
57
179
1137
11698
260
1232
911
10446
453
2816
626
7820
Shoulder X-ray examination without contrast
NB1AA [2001307225]
1.2e+00
2.3e+00
—
1.0e+50
—
2.8e+00
1.3e+00
cases:1.34%
controls:0.40%
cases:1.26%
controls:0.13%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.02%
controls:0.06%
cases:1.20%
controls:0.32%
16
48
1178
11845
15
15
1179
11878
—
8
0
1186
11893
—
12
7
1159
11671
13
34
1066
10602
amitriptyline; oral, parenteral
N06AA09 [21604696]
9.7e-01
1.4e+00
1.2e+00
—
1.7e+00
1.4e+00
9.7e-01
cases:5.78%
controls:2.28%
cases:4.52%
controls:1.11%
cases:1.09%
controls:0.34%
—
—
cases:1.51%
controls:0.28%
cases:4.87%
controls:1.21%
cases:7.51%
controls:3.00%
69
271
1125
11622
54
132
1140
11761
13
40
1181
11853
—
18
33
1176
11844
57
141
1114
11537
81
319
998
10317
Hand/finger symptom/complaint
L12 [2002000636]
3.6e-01
1.4e+00
—
—
3.2e+00
1.6e+00
1.4e+00
cases:1.59%
controls:1.12%
cases:1.59%
controls:0.39%
—
—
—
—
cases:1.01%
controls:0.04%
cases:1.45%
controls:0.28%
cases:4.54%
controls:1.13%
19
133
1175
11760
19
46
1175
11847
—
—
12
5
1182
11872
17
33
1154
11645
49
120
1030
10516
Office Visit
OMOP4822458 [581477]
6.7e-01
1.4e+00
1.6e+00
1.0e+50
1.9e+00
1.4e+00
7.6e-01
cases:10.72%
controls:5.80%
cases:6.87%
controls:1.88%
cases:1.34%
controls:0.29%
cases:1.42%
controls:0.00%
cases:1.76%
controls:0.28%
cases:6.75%
controls:1.70%
cases:11.03%
controls:5.50%
128
690
1066
11203
82
223
1112
11670
16
34
1178
11859
17
0
1177
11893
21
33
1173
11844
79
199
1092
11479
119
585
960
10051
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.6e+00
1.9e+00
—
—
—
2.3e+00
1.4e+00
cases:2.18%
controls:0.46%
cases:1.26%
controls:0.18%
—
—
—
—
—
—
cases:1.79%
controls:0.19%
cases:2.87%
controls:0.71%
26
55
1168
11838
15
22
1179
11871
—
—
—
21
22
1150
11656
31
75
1048
10561
codeine and paracetamol
N02AJ06 [1123647]
6.3e-01
1.2e+00
1.5e+00
1.0e+50
1.8e+00
1.2e+00
8.2e-01
cases:15.49%
controls:8.86%
cases:10.80%
controls:3.36%
cases:2.51%
controls:0.58%
cases:1.68%
controls:0.00%
cases:3.35%
controls:0.56%
cases:9.99%
controls:3.37%
cases:21.22%
controls:10.61%
185
1054
1009
10839
129
400
1065
11493
30
69
1164
11824
20
0
1174
11893
40
66
1154
11811
117
394
1054
11284
229
1129
850
9507
Adhesive capsulitis of shoulder
M75.0 [45533931]
1.6e+00
1.9e+00
—
—
—
2.6e+00
1.1e+00
cases:1.34%
controls:0.28%
cases:1.17%
controls:0.18%
—
—
—
—
—
—
cases:1.28%
controls:0.09%
cases:1.58%
controls:0.54%
16
33
1178
11860
14
22
1180
11871
—
—
—
15
11
1156
11667
17
57
1062
10579
Lateral epicondylitis
M77.1 [45572551]
1.1e+00
2.7e+00
—
—
—
2.1e+00
1.2e+00
cases:1.34%
controls:0.45%
cases:1.93%
controls:0.13%
—
—
—
—
—
—
cases:1.45%
controls:0.17%
cases:2.22%
controls:0.71%
16
54
1178
11839
23
16
1171
11877
—
—
—
17
20
1154
11658
24
76
1055
10560
Wrist X-ray examination
ND1AA [2001307576]
1.3e+00
2.6e+00
—
—
—
2.1e+00
1.1e+00
cases:1.17%
controls:0.32%
cases:1.09%
controls:0.08%
—
—
—
—
—
—
cases:0.94%
controls:0.12%
cases:1.20%
controls:0.41%
14
38
1180
11855
13
10
1181
11883
—
—
—
11
14
1160
11664
13
44
1066
10592
Cervical spine X-ray examination without contrast
NA1AA [2001306981]
1.9e+00
2.4e+00
—
—
—
—
2.6e+00
cases:0.92%
controls:0.14%
cases:0.67%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.08%
11
17
1183
11876
8
7
1186
11886
—
—
—
—
11
8
1068
10628
Cervicobrachial syndrome
M53.1 [45567577]
1.3e+00
2.0e+00
—
1.0e+50
—
2.2e+00
1.5e+00
cases:2.51%
controls:0.73%
cases:2.26%
controls:0.30%
—
—
cases:0.59%
controls:0.00%
—
—
cases:2.39%
controls:0.28%
cases:3.71%
controls:0.86%
30
87
1164
11806
27
36
1167
11857
—
7
0
1187
11893
—
28
33
1143
11645
40
92
1039
10544
Pain in joint
M25.5 [45586941]
1.1e+00
1.5e+00
2.1e+00
—
—
1.2e+00
9.2e-01
cases:6.95%
controls:2.45%
cases:3.69%
controls:0.85%
cases:0.92%
controls:0.11%
—
—
—
—
cases:3.59%
controls:1.06%
cases:8.43%
controls:3.55%
83
291
1111
11602
44
101
1150
11792
11
13
1183
11880
—
—
42
124
1129
11554
91
378
988
10258
Other chronic pain
R52.2 [45568139]
2.3e+00
—
—
—
—
2.5e+00
2.1e+00
cases:0.84%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.05%
cases:1.02%
controls:0.13%
10
10
1184
11883
—
—
—
—
7
6
1164
11672
11
14
1068
10622
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.8e+00
1.6e+00
—
—
—
1.9e+00
1.5e+00
cases:2.18%
controls:0.38%
cases:0.67%
controls:0.13%
—
—
—
—
—
—
cases:0.68%
controls:0.10%
cases:1.67%
controls:0.38%
26
45
1168
11848
8
16
1186
11877
—
—
—
8
12
1163
11666
18
40
1061
10596
oxycodone; oral, parenteral
N02AA05 [21604260]
1.1e+00
1.3e+00
1.5e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:1.76%
controls:0.59%
cases:1.09%
controls:0.30%
cases:0.50%
controls:0.11%
—
—
cases:0.75%
controls:0.12%
cases:1.45%
controls:0.43%
cases:2.87%
controls:0.97%
21
70
1173
11823
13
36
1181
11857
6
13
1188
11880
—
9
14
1185
11863
17
50
1154
11628
31
103
1048
10533
Trigger finger
M65.3 [45538828]
2.0e+00
2.1e+00
—
—
—
2.6e+00
2.0e+00
cases:1.09%
controls:0.15%
cases:0.42%
controls:0.05%
—
—
—
—
—
—
cases:0.68%
controls:0.05%
cases:1.76%
controls:0.24%
13
18
1181
11875
5
6
1189
11887
—
—
—
8
6
1163
11672
19
26
1060
10610
Primary arthrosis of other joints
M19.0 [45601353]
1.1e+00
1.7e+00
—
1.0e+50
—
2.3e+00
1.2e+00
cases:1.59%
controls:0.53%
cases:1.42%
controls:0.25%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.96%
controls:0.21%
cases:2.78%
controls:0.88%
19
63
1175
11830
17
30
1177
11863
—
8
0
1186
11893
—
23
24
1148
11654
30
94
1049
10542
Other spondylosis, multiple sites in spine
M47.80 [42617655]
1.8e+00
2.1e+00
—
—
—
2.3e+00
1.1e+00
cases:0.84%
controls:0.13%
cases:0.50%
controls:0.06%
—
—
—
—
—
—
cases:0.60%
controls:0.06%
cases:0.56%
controls:0.19%
10
16
1184
11877
6
7
1188
11886
—
—
—
7
7
1164
11671
6
20
1073
10616
Hand and fingers X-ray examination
ND2AA [2001307607]
1.1e+00
1.9e+00
—
—
—
2.0e+00
1.2e+00
cases:1.68%
controls:0.55%
cases:0.92%
controls:0.13%
—
—
—
—
—
—
cases:0.94%
controls:0.13%
cases:1.95%
controls:0.59%
20
65
1174
11828
11
16
1183
11877
—
—
—
11
15
1160
11663
21
63
1058
10573
Other rehabilitation service
R5599 [2001310270]
1.7e+00
—
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.67%
controls:0.13%
—
—
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.51%
controls:0.04%
cases:0.74%
controls:0.09%
8
15
1186
11878
—
—
8
0
1186
11893
—
6
5
1165
11673
8
10
1071
10626
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.3e-01
5.1e-01
6.4e-01
3.2e+00
7.3e-01
6.1e-01
4.7e-01
cases:19.01%
controls:15.72%
cases:15.41%
controls:9.88%
cases:3.10%
controls:1.66%
cases:2.93%
controls:0.12%
cases:3.52%
controls:1.73%
cases:16.91%
controls:9.92%
cases:32.72%
controls:23.24%
227
1869
967
10024
184
1175
1010
10718
37
197
1157
11696
35
14
1159
11879
42
206
1152
11671
198
1159
973
10519
353
2472
726
8164
codeine and ibuprofen
N02AJ08 [1123631]
2.6e+00
2.1e+00
—
—
—
—
1.6e+00
cases:1.09%
controls:0.08%
cases:0.59%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.24%
13
10
1181
11883
7
9
1187
11884
—
—
—
—
12
25
1067
10611
Left side
ZXA05 [2001311347]
8.4e-01
8.8e-01
—
—
2.5e+00
2.0e+00
8.3e-01
cases:3.85%
controls:1.71%
cases:1.51%
controls:0.63%
—
—
—
—
cases:0.50%
controls:0.04%
cases:3.25%
controls:0.46%
cases:4.54%
controls:2.04%
46
203
1148
11690
18
75
1176
11818
—
—
6
5
1188
11872
38
54
1133
11624
49
217
1030
10419
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.1e+00
1.2e+00
2.1e+00
—
—
1.8e+00
1.1e+00
cases:1.51%
controls:0.53%
cases:0.75%
controls:0.24%
cases:0.50%
controls:0.06%
—
—
—
—
cases:0.85%
controls:0.15%
cases:1.85%
controls:0.63%
18
63
1176
11830
9
28
1185
11865
6
7
1188
11886
—
—
10
17
1161
11661
20
67
1059
10569
Removal of sutures
SPAT1153 [2001700254]
6.8e-01
1.0e+00
-1.0e+50
—
2.1e+00
1.5e+00
8.0e-01
cases:4.94%
controls:2.56%
cases:2.26%
controls:0.81%
cases:0.00%
controls:0.06%
—
—
cases:0.59%
controls:0.08%
cases:2.56%
controls:0.59%
cases:5.93%
controls:2.75%
59
305
1135
11588
27
96
1167
11797
0
7
1194
11886
—
7
9
1187
11868
30
69
1141
11609
64
292
1015
10344
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.2e-01
4.3e-01
7.9e-01
3.3e+00
6.7e-01
4.8e-01
3.3e-01
cases:19.10%
controls:15.91%
cases:17.25%
controls:11.91%
cases:4.61%
controls:2.15%
cases:3.02%
controls:0.11%
cases:4.02%
controls:2.10%
cases:18.19%
controls:12.07%
cases:32.25%
controls:25.58%
228
1892
966
10001
206
1416
988
10477
55
256
1139
11637
36
13
1158
11880
48
249
1146
11628
213
1409
958
10269
348
2721
731
7915
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
1.1e+00
1.8e+00
1.7e+00
1.0e+50
1.1e+00
1.9e+00
1.2e+00
cases:3.27%
controls:1.14%
cases:2.26%
controls:0.37%
cases:0.50%
controls:0.09%
cases:0.50%
controls:0.00%
cases:0.42%
controls:0.13%
cases:2.48%
controls:0.37%
cases:3.89%
controls:1.25%
39
136
1155
11757
27
44
1167
11849
6
11
1188
11882
6
0
1188
11893
5
16
1189
11861
29
43
1142
11635
42
133
1037
10503
Scheduled procedure
ZXD10 [2001311387]
6.3e-01
1.0e+00
1.8e+00
—
1.4e+00
1.6e+00
9.4e-01
cases:7.87%
controls:4.36%
cases:3.69%
controls:1.37%
cases:0.84%
controls:0.14%
—
—
cases:0.59%
controls:0.14%
cases:5.12%
controls:1.04%
cases:8.71%
controls:3.61%
94
518
1100
11375
44
163
1150
11730
10
17
1184
11876
—
7
17
1187
11860
60
122
1111
11556
94
384
985
10252
Emergency Room Visit
ER [9203]
6.9e-01
1.0e+00
1.4e+00
—
1.3e+00
8.5e-01
7.5e-01
cases:40.45%
controls:25.36%
cases:20.77%
controls:8.79%
cases:3.77%
controls:0.98%
—
—
cases:3.35%
controls:0.93%
cases:17.76%
controls:8.48%
cases:41.43%
controls:25.00%
483
3016
711
8877
248
1045
946
10848
45
116
1149
11777
—
40
110
1154
11767
208
990
963
10688
447
2659
632
7977
duloxetine; oral
N06AX21 [21604749]
1.4e+00
1.6e+00
—
—
1.3e+00
1.6e+00
1.4e+00
cases:3.18%
controls:0.77%
cases:2.26%
controls:0.47%
—
—
—
—
cases:0.59%
controls:0.17%
cases:2.48%
controls:0.51%
cases:4.54%
controls:1.21%
38
92
1156
11801
27
56
1167
11837
—
—
7
20
1187
11857
29
60
1142
11618
49
129
1030
10507
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.2e-01
4.3e-01
7.6e-01
3.3e+00
7.0e-01
4.8e-01
3.2e-01
cases:18.93%
controls:15.79%
cases:17.09%
controls:11.82%
cases:4.44%
controls:2.13%
cases:3.02%
controls:0.12%
cases:4.02%
controls:2.04%
cases:18.02%
controls:11.95%
cases:31.88%
controls:25.36%
226
1878
968
10015
204
1406
990
10487
53
253
1141
11640
36
14
1158
11879
48
242
1146
11635
211
1395
960
10283
344
2697
735
7939
Pharmacy visit
OMOP4822462 [581458]
4.0e-01
8.5e-01
6.6e-01
1.8e+00
7.1e-01
7.8e-01
7.6e-01
cases:88.78%
controls:84.12%
cases:85.68%
controls:71.83%
cases:48.83%
controls:32.94%
cases:9.30%
controls:1.69%
cases:50.42%
controls:33.22%
cases:85.65%
controls:73.33%
cases:95.74%
controls:91.31%
1060
10004
134
1889
1023
8543
171
3350
583
3918
611
7975
111
201
1083
11692
602
3946
592
7931
1003
8563
168
3115
1033
9712
46
924
Laceration/cut
S18 [2002000983]
7.1e-01
1.1e+00
1.1e+00
—
2.1e+00
1.4e+00
6.8e-01
cases:7.04%
controls:3.59%
cases:4.02%
controls:1.42%
cases:0.50%
controls:0.17%
—
—
cases:1.17%
controls:0.14%
cases:4.78%
controls:1.27%
cases:9.27%
controls:4.93%
84
427
1110
11466
48
169
1146
11724
6
20
1188
11873
—
14
17
1180
11860
56
148
1115
11530
100
524
979
10112
etoricoxib; oral
M01AH05 [21603996]
6.2e-01
1.1e+00
1.4e+00
—
1.2e+00
8.7e-01
7.1e-01
cases:16.92%
controls:9.91%
cases:11.22%
controls:4.00%
cases:2.26%
controls:0.55%
—
—
cases:2.09%
controls:0.64%
cases:9.48%
controls:4.20%
cases:22.52%
controls:12.53%
202
1179
992
10714
134
476
1060
11417
27
66
1167
11827
—
25
76
1169
11801
111
491
1060
11187
243
1333
836
9303
Post-traumatic stress disorder
F43.1 [45595909]
1.4e+00
2.1e+00
—
—
—
2.2e+00
1.5e+00
cases:0.67%
controls:0.16%
cases:0.67%
controls:0.08%
—
—
—
—
—
—
cases:0.68%
controls:0.08%
cases:1.20%
controls:0.28%
8
19
1186
11874
8
10
1186
11883
—
—
—
8
9
1163
11669
13
30
1066
10606
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.6e-01
3.6e-01
6.5e-01
3.2e+00
6.2e-01
5.1e-01
3.5e-01
cases:16.16%
controls:12.98%
cases:14.15%
controls:10.34%
cases:4.10%
controls:2.18%
cases:2.68%
controls:0.12%
cases:3.77%
controls:2.06%
cases:16.23%
controls:10.38%
cases:27.06%
controls:20.80%
193
1544
1001
10349
169
1230
1025
10663
49
259
1145
11634
32
14
1162
11879
45
245
1149
11632
190
1212
981
10466
292
2212
787
8424
Case Management Agency
251B00000X [38004193]
3.0e-01
2.2e-01
5.5e-01
3.4e+00
6.5e-01
2.7e-01
2.3e-01
cases:49.58%
controls:42.25%
cases:41.71%
controls:36.48%
cases:20.69%
controls:13.05%
cases:18.59%
controls:0.75%
cases:22.95%
controls:13.44%
cases:44.41%
controls:37.88%
cases:62.37%
controls:56.89%
592
5025
602
6868
498
4339
696
7554
247
1552
947
10341
222
89
972
11804
274
1596
920
10281
520
4424
651
7254
673
6051
406
4585
General Practice
1 [38004446]
4.6e-01
8.8e-01
1.3e+00
1.0e+50
1.5e+00
7.7e-01
7.0e-01
cases:11.98%
controls:7.90%
cases:6.70%
controls:2.89%
cases:1.26%
controls:0.35%
cases:4.36%
controls:0.00%
cases:1.68%
controls:0.37%
cases:6.58%
controls:3.16%
cases:16.77%
controls:9.09%
143
940
1051
10953
80
344
1114
11549
15
42
1179
11851
52
0
1142
11893
20
44
1174
11833
77
369
1094
11309
181
967
898
9669
Radiculopathy
M54.1 [45577287]
1.8e+00
2.3e+00
—
—
—
—
1.4e+00
cases:0.75%
controls:0.13%
cases:0.59%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.24%
9
15
1185
11878
7
7
1187
11886
—
—
—
—
10
25
1069
10611
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
6.5e-01
2.2e+00
—
—
—
1.9e+00
1.3e+00
cases:1.09%
controls:0.57%
cases:1.68%
controls:0.18%
—
—
—
—
—
—
cases:1.28%
controls:0.19%
cases:2.22%
controls:0.60%
13
68
1181
11825
20
22
1174
11871
—
—
—
15
22
1156
11656
24
64
1055
10572
CBC panel - Blood by Automated count
58410-2 [40761511]
2.1e-01
3.5e-01
6.8e-01
3.0e+00
7.3e-01
3.8e-01
2.4e-01
cases:20.44%
controls:17.20%
cases:15.58%
controls:11.50%
cases:3.43%
controls:1.77%
cases:1.59%
controls:0.08%
cases:3.60%
controls:1.77%
cases:15.80%
controls:11.39%
cases:31.51%
controls:26.56%
244
2046
950
9847
186
1368
1008
10525
41
211
1153
11682
19
10
1175
11883
43
210
1151
11667
185
1330
986
10348
340
2825
739
7811
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.6e-01
3.3e-01
5.8e-01
3.0e+00
6.5e-01
4.3e-01
2.9e-01
cases:20.27%
controls:17.78%
cases:18.84%
controls:14.29%
cases:5.03%
controls:2.87%
cases:3.02%
controls:0.15%
cases:5.03%
controls:2.68%
cases:21.01%
controls:14.79%
cases:35.59%
controls:29.18%
242
2115
952
9778
225
1700
969
10193
60
341
1134
11552
36
18
1158
11875
60
318
1134
11559
246
1727
925
9951
384
3104
695
7532
ENMG
XA402 [2001300405]
3.0e+00
—
—
1.0e+50
—
1.0e+50
2.3e+00
cases:1.17%
controls:0.06%
—
—
—
—
cases:0.92%
controls:0.00%
—
—
cases:1.45%
controls:0.00%
cases:0.93%
controls:0.09%
14
7
1180
11886
—
—
11
0
1183
11893
—
17
0
1154
11678
10
10
1069
10626
Other physical therapy
Z50.1 [45600331]
9.7e-01
1.7e+00
—
—
—
2.4e+00
1.1e+00
cases:0.84%
controls:0.32%
cases:0.67%
controls:0.12%
—
—
—
—
—
—
cases:1.71%
controls:0.16%
cases:1.58%
controls:0.51%
10
38
1184
11855
8
14
1186
11879
—
—
—
20
19
1151
11659
17
54
1062
10582
Outpatient Hospital
22 [8756]
6.7e-01
9.5e-01
8.7e-01
—
1.6e+00
1.2e+00
7.8e-01
cases:30.99%
controls:18.62%
cases:13.74%
controls:5.81%
cases:1.51%
controls:0.64%
—
—
cases:3.02%
controls:0.64%
cases:15.37%
controls:4.96%
cases:30.03%
controls:16.43%
370
2215
824
9678
164
691
1030
11202
18
76
1176
11817
—
36
76
1158
11801
180
579
991
11099
324
1748
755
8888
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.8e-01
2.7e-01
6.5e-01
3.1e+00
7.4e-01
4.2e-01
3.3e-01
cases:14.24%
controls:12.20%
cases:12.23%
controls:9.61%
cases:3.69%
controls:1.97%
cases:2.35%
controls:0.11%
cases:3.69%
controls:1.79%
cases:14.77%
controls:10.22%
cases:25.86%
controls:20.05%
170
1451
1024
10442
146
1143
1048
10750
44
234
1150
11659
28
13
1166
11880
44
213
1150
11664
173
1193
998
10485
279
2133
800
8503
Other specified counselling
Z71.8 [45581061]
6.9e-01
1.1e+00
7.7e-01
—
1.8e+00
9.5e-01
6.6e-01
cases:4.52%
controls:2.33%
cases:2.93%
controls:1.03%
cases:0.42%
controls:0.19%
—
—
cases:0.84%
controls:0.13%
cases:3.25%
controls:1.28%
cases:7.14%
controls:3.82%
54
277
1140
11616
35
122
1159
11771
5
23
1189
11870
—
10
16
1184
11861
38
149
1133
11529
77
406
1002
10230
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
7.4e-01
1.2e+00
1.0e+00
1.0e+50
1.2e+00
4.8e-01
5.9e-01
cases:24.96%
controls:13.71%
cases:12.65%
controls:4.29%
cases:1.34%
controls:0.50%
cases:0.59%
controls:0.00%
cases:1.93%
controls:0.59%
cases:7.00%
controls:4.44%
cases:23.54%
controls:14.52%
298
1630
896
10263
151
510
1043
11383
16
59
1178
11834
7
0
1187
11893
23
70
1171
11807
82
519
1089
11159
254
1544
825
9092
Headache
R51.80 [2000503603]
9.7e-01
1.7e+00
—
—
—
1.4e+00
1.1e+00
cases:3.52%
controls:1.36%
cases:1.42%
controls:0.25%
—
—
—
—
—
—
cases:1.62%
controls:0.42%
cases:3.71%
controls:1.27%
42
162
1152
11731
17
30
1177
11863
—
—
—
19
49
1152
11629
40
135
1039
10501
Other specified intervertebral disc degeneration
M51.3 [45591865]
8.4e-01
1.9e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:1.26%
controls:0.55%
cases:1.34%
controls:0.19%
—
—
cases:0.59%
controls:0.00%
—
—
cases:1.37%
controls:0.20%
cases:2.59%
controls:0.74%
15
65
1179
11828
16
23
1178
11870
—
7
0
1187
11893
—
16
23
1155
11655
28
79
1051
10557
Exposure to other specified factors
X58 [45756411]
1.3e+00
1.2e+00
1.8e+00
1.0e+50
2.1e+00
1.5e+00
1.1e+00
cases:3.27%
controls:0.95%
cases:1.68%
controls:0.50%
cases:0.50%
controls:0.08%
cases:0.42%
controls:0.00%
cases:0.42%
controls:0.05%
cases:1.62%
controls:0.38%
cases:3.34%
controls:1.11%
39
113
1155
11780
20
59
1174
11834
6
10
1188
11883
5
0
1189
11893
5
6
1189
11871
19
44
1152
11634
36
118
1043
10518
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]
7.9e-01
1.8e+00
—
1.0e+50
—
2.2e+00
1.0e+00
cases:1.09%
controls:0.50%
cases:1.17%
controls:0.19%
—
—
cases:0.42%
controls:0.00%
—
—
cases:1.02%
controls:0.11%
cases:1.95%
controls:0.72%
13
59
1181
11834
14
23
1180
11870
—
5
0
1189
11893
—
12
13
1159
11665
21
77
1058
10559
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.9e+00
1.9e+00
—
—
1.0e+50
1.8e+00
1.2e+00
cases:1.51%
controls:0.23%
cases:0.59%
controls:0.08%
—
—
—
—
cases:0.42%
controls:0.00%
cases:0.51%
controls:0.09%
cases:1.30%
controls:0.40%
18
27
1176
11866
7
10
1187
11883
—
—
5
0
1189
11877
6
10
1165
11668
14
43
1065
10593
esomeprazole; oral, parenteral
A02BC05 [21600100]
6.0e-01
8.8e-01
1.1e+00
—
1.0e+00
6.6e-01
7.7e-01
cases:10.30%
controls:5.94%
cases:6.45%
controls:2.77%
cases:1.93%
controls:0.68%
—
—
cases:1.59%
controls:0.56%
cases:5.72%
controls:3.03%
cases:14.27%
controls:7.14%
123
706
1071
11187
77
330
1117
11563
23
81
1171
11812
—
19
67
1175
11810
67
354
1104
11324
154
759
925
9877
Bacteria [Presence] in Urine
87829-8 [36304419]
8.0e-01
7.7e-01
—
—
1.7e+00
8.9e-01
8.0e-01
cases:4.86%
controls:2.25%
cases:2.43%
controls:1.14%
—
—
—
—
cases:0.67%
controls:0.12%
cases:2.56%
controls:1.07%
cases:6.39%
controls:2.97%
58
268
1136
11625
29
135
1165
11758
—
—
8
14
1186
11863
30
125
1141
11553
69
316
1010
10320
Right side
ZXA00 [2001311346]
7.5e-01
1.0e+00
—
1.0e+50
2.0e+00
2.2e+00
1.0e+00
cases:4.02%
controls:1.94%
cases:1.68%
controls:0.62%
—
—
cases:0.50%
controls:0.00%
cases:0.42%
controls:0.06%
cases:3.50%
controls:0.41%
cases:5.65%
controls:2.06%
48
231
1146
11662
20
74
1174
11819
—
6
0
1188
11893
5
7
1189
11870
41
48
1130
11630
61
219
1018
10417
Shoulder lesion, unspecified
M75.9 [45557986]
9.2e-01
2.8e+00
—
1.0e+50
—
2.1e+00
9.7e-01
cases:0.75%
controls:0.30%
cases:1.51%
controls:0.09%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.51%
controls:0.06%
cases:0.74%
controls:0.28%
9
36
1185
11857
18
11
1176
11882
—
5
0
1189
11893
—
6
7
1165
11671
8
30
1071
10606
Spinal stenosis
M48.0 [45557888]
9.2e-01
1.4e+00
—
—
1.1e+00
1.5e+00
1.2e+00
cases:1.68%
controls:0.67%
cases:1.26%
controls:0.33%
—
—
—
—
cases:0.42%
controls:0.14%
cases:1.28%
controls:0.29%
cases:2.69%
controls:0.84%
20
80
1174
11813
15
39
1179
11854
—
—
5
17
1189
11860
15
34
1156
11644
29
89
1050
10547
Neck symptom/complaint
L01 [2002000626]
8.1e-01
1.9e+00
—
—
—
1.2e+00
1.0e+00
cases:2.01%
controls:0.91%
cases:2.01%
controls:0.31%
—
—
—
—
—
—
cases:1.28%
controls:0.38%
cases:3.34%
controls:1.22%
24
108
1170
11785
24
37
1170
11856
—
—
—
15
44
1156
11634
36
130
1043
10506
MCH [Entitic mass]
28539-5 [3035941]
1.3e-01
3.3e-01
6.2e-01
2.7e+00
6.1e-01
4.1e-01
2.2e-01
cases:22.61%
controls:20.49%
cases:21.86%
controls:16.79%
cases:6.20%
controls:3.45%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.38%
cases:24.00%
controls:17.38%
cases:38.46%
controls:33.33%
270
2437
924
9456
261
1997
933
9896
74
410
1120
11483
36
24
1158
11869
72
401
1122
11476
281
2030
890
9648
415
3545
664
7091
Platelets [#/volume] in Blood
26515-7 [3007461]
1.1e-01
3.2e-01
6.2e-01
2.7e+00
6.1e-01
4.1e-01
2.3e-01
cases:22.45%
controls:20.51%
cases:21.69%
controls:16.77%
cases:6.20%
controls:3.45%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.37%
cases:24.00%
controls:17.36%
cases:38.37%
controls:33.17%
268
2439
926
9454
259
1995
935
9898
74
410
1120
11483
36
24
1158
11869
72
400
1122
11477
281
2027
890
9651
414
3528
665
7108
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.2e-01
3.2e-01
6.3e-01
2.7e+00
6.0e-01
4.1e-01
2.3e-01
cases:22.61%
controls:20.58%
cases:21.78%
controls:16.83%
cases:6.28%
controls:3.44%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.42%
cases:24.08%
controls:17.44%
cases:38.55%
controls:33.38%
270
2448
924
9445
260
2002
934
9891
75
409
1119
11484
36
24
1158
11869
72
406
1122
11471
282
2037
889
9641
416
3550
663
7086
Psychiatry
26 [38004469]
6.3e-01
8.5e-01
8.8e-01
—
7.8e-01
8.7e-01
9.1e-01
cases:8.46%
controls:4.68%
cases:5.44%
controls:2.41%
cases:2.09%
controls:0.88%
—
—
cases:1.93%
controls:0.89%
cases:5.64%
controls:2.45%
cases:11.03%
controls:4.76%
101
556
1093
11337
65
287
1129
11606
25
105
1169
11788
—
23
106
1171
11771
66
286
1105
11392
119
506
960
10130
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
3.2e-01
6.2e-01
2.7e+00
6.1e-01
4.1e-01
2.2e-01
cases:22.61%
controls:20.56%
cases:21.78%
controls:16.81%
cases:6.20%
controls:3.44%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.38%
cases:24.08%
controls:17.41%
cases:38.46%
controls:33.32%
270
2445
924
9448
260
1999
934
9894
74
409
1120
11484
36
24
1158
11869
72
402
1122
11475
282
2033
889
9645
415
3544
664
7092
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
3.2e-01
6.2e-01
2.7e+00
6.0e-01
4.1e-01
2.2e-01
cases:22.61%
controls:20.55%
cases:21.78%
controls:16.83%
cases:6.20%
controls:3.45%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.40%
cases:24.17%
controls:17.42%
cases:38.46%
controls:33.33%
270
2444
924
9449
260
2001
934
9892
74
410
1120
11483
36
24
1158
11869
72
404
1122
11473
283
2034
888
9644
415
3545
664
7091
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
3.2e-01
6.2e-01
2.7e+00
6.0e-01
4.1e-01
2.2e-01
cases:22.61%
controls:20.55%
cases:21.78%
controls:16.83%
cases:6.20%
controls:3.45%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.40%
cases:24.08%
controls:17.43%
cases:38.46%
controls:33.33%
270
2444
924
9449
260
2002
934
9891
74
410
1120
11483
36
24
1158
11869
72
404
1122
11473
282
2035
889
9643
415
3545
664
7091
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.2e-01
3.2e-01
6.1e-01
2.7e+00
6.0e-01
4.0e-01
2.2e-01
cases:22.61%
controls:20.58%
cases:21.78%
controls:16.85%
cases:6.20%
controls:3.47%
cases:3.02%
controls:0.20%
cases:6.03%
controls:3.41%
cases:24.08%
controls:17.48%
cases:38.55%
controls:33.41%
270
2447
924
9446
260
2004
934
9889
74
413
1120
11480
36
24
1158
11869
72
405
1122
11472
282
2041
889
9637
416
3554
663
7082
Axillary plexus blockaced
WX204 [2001310780]
1.5e+00
—
—
—
—
2.5e+00
2.4e+00
cases:0.50%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:1.02%
controls:0.09%
6
13
1188
11880
—
—
—
—
6
5
1165
11673
11
10
1068
10626
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
5.9e-01
8.1e-01
7.4e-01
—
1.5e+00
7.5e-01
5.3e-01
cases:42.04%
controls:28.69%
cases:25.88%
controls:13.45%
cases:3.77%
controls:1.83%
—
—
cases:6.11%
controls:1.50%
cases:25.02%
controls:13.61%
cases:47.17%
controls:34.51%
502
3412
692
8481
309
1600
885
10293
45
218
1149
11675
—
73
178
1121
11699
293
1589
878
10089
509
3671
570
6965
ibuprofen
R02AX02 [1588667]
5.9e-01
8.1e-01
7.4e-01
—
1.5e+00
7.5e-01
5.3e-01
cases:42.04%
controls:28.69%
cases:25.88%
controls:13.45%
cases:3.77%
controls:1.83%
—
—
cases:6.11%
controls:1.50%
cases:25.02%
controls:13.61%
cases:47.17%
controls:34.51%
502
3412
692
8481
309
1600
885
10293
45
218
1149
11675
—
73
178
1121
11699
293
1589
878
10089
509
3671
570
6965
Pain in thoracic spine
M54.6 [45606247]
1.3e+00
2.0e+00
—
1.0e+50
—
1.6e+00
6.0e-01
cases:1.26%
controls:0.36%
cases:0.67%
controls:0.09%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.94%
controls:0.19%
cases:1.30%
controls:0.71%
15
43
1179
11850
8
11
1186
11882
—
5
0
1189
11893
—
11
22
1160
11656
14
76
1065
10560
Tension-type headache
G44.2 [45581495]
9.1e-01
1.3e+00
—
—
—
1.5e+00
1.2e+00
cases:2.18%
controls:0.89%
cases:1.09%
controls:0.31%
—
—
—
—
—
—
cases:1.45%
controls:0.34%
cases:3.24%
controls:1.02%
26
106
1168
11787
13
37
1181
11856
—
—
—
17
40
1154
11638
35
109
1044
10527
Myalgia
M79.1 [45587062]
1.0e+00
1.3e+00
—
—
—
1.4e+00
1.1e+00
cases:2.51%
controls:0.92%
cases:1.26%
controls:0.34%
—
—
—
—
—
—
cases:1.11%
controls:0.28%
cases:3.61%
controls:1.25%
30
110
1164
11783
15
41
1179
11852
—
—
—
13
33
1158
11645
39
133
1040
10503
Internal Medicine
11 [38004456]
6.3e-01
8.7e-01
8.9e-01
—
9.0e-01
7.6e-01
7.1e-01
cases:26.80%
controls:16.25%
cases:14.41%
controls:6.60%
cases:2.60%
controls:1.08%
—
—
cases:2.51%
controls:1.04%
cases:13.24%
controls:6.67%
cases:28.08%
controls:16.07%
320
1933
874
9960
172
785
1022
11108
31
129
1163
11764
—
30
123
1164
11754
155
779
1016
10899
303
1709
776
8927
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.2e-01
8.6e-01
—
—
2.1e+00
1.1e+00
6.9e-01
cases:4.02%
controls:2.44%
cases:2.76%
controls:1.19%
—
—
—
—
cases:0.75%
controls:0.09%
cases:2.82%
controls:0.98%
cases:5.93%
controls:3.07%
48
290
1146
11603
33
141
1161
11752
—
—
9
11
1185
11866
33
115
1138
11563
64
326
1015
10310
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
1.2e+00
—
—
—
—
1.8e+00
1.6e+00
cases:1.17%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.14%
cases:1.58%
controls:0.32%
14
43
1180
11850
—
—
—
—
10
16
1161
11662
17
34
1062
10602
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.5e+00
7.7e-01
—
—
—
1.7e+00
1.3e+00
cases:2.01%
controls:0.44%
cases:0.42%
controls:0.19%
—
—
—
—
—
—
cases:0.77%
controls:0.15%
cases:2.04%
controls:0.55%
24
52
1170
11841
5
23
1189
11870
—
—
—
9
17
1162
11661
22
59
1057
10577
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.2e+00
1.3e+00
—
—
—
1.9e+00
1.3e+00
cases:1.93%
controls:0.57%
cases:0.75%
controls:0.20%
—
—
—
—
—
—
cases:1.11%
controls:0.16%
cases:2.41%
controls:0.64%
23
68
1171
11825
9
24
1185
11869
—
—
—
13
19
1158
11659
26
68
1053
10568
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
8.4e-01
—
—
—
—
2.6e+00
1.8e+00
cases:0.50%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.05%
cases:1.30%
controls:0.21%
6
26
1188
11867
—
—
—
—
8
6
1163
11672
14
22
1065
10614
Arm symptom/complaint
L09 [2002000633]
8.2e-01
2.4e+00
—
—
—
2.0e+00
1.1e+00
cases:0.42%
controls:0.18%
cases:0.75%
controls:0.07%
—
—
—
—
—
—
cases:0.51%
controls:0.07%
cases:0.74%
controls:0.25%
5
22
1189
11871
9
8
1185
11885
—
—
—
6
8
1165
11670
8
27
1071
10609
Rheumatology
66 [38004491]
8.4e-01
1.2e+00
7.3e-01
—
1.2e+00
1.2e+00
1.1e+00
cases:4.52%
controls:2.00%
cases:3.43%
controls:1.03%
cases:0.42%
controls:0.20%
—
—
cases:0.67%
controls:0.20%
cases:3.50%
controls:1.07%
cases:6.39%
controls:2.18%
54
238
1140
11655
41
122
1153
11771
5
24
1189
11869
—
8
24
1186
11853
41
125
1130
11553
69
232
1010
10404
clonazepam; oral, parenteral
N03AE01 [21604415]
8.5e-01
1.3e+00
—
—
—
1.5e+00
1.7e+00
cases:1.42%
controls:0.61%
cases:1.09%
controls:0.31%
—
—
—
—
—
—
cases:1.62%
controls:0.38%
cases:2.97%
controls:0.58%
17
73
1177
11820
13
37
1181
11856
—
—
—
19
44
1152
11634
32
62
1047
10574
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
2.2e+00
—
—
—
—
1.8e+00
2.2e+00
cases:0.67%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:0.83%
controls:0.09%
8
9
1186
11884
—
—
—
—
5
8
1166
11670
9
10
1070
10626
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.0e+00
1.1e+00
1.0e+00
—
9.5e-01
1.2e+00
1.1e+00
cases:5.03%
controls:1.85%
cases:2.60%
controls:0.89%
cases:0.75%
controls:0.27%
—
—
cases:0.67%
controls:0.26%
cases:2.99%
controls:0.92%
cases:5.28%
controls:1.91%
60
220
1134
11673
31
106
1163
11787
9
32
1185
11861
—
8
31
1186
11846
35
107
1136
11571
57
203
1022
10433
More than three and less than five hours
ZXE20 [2001311408]
7.3e-01
1.5e+00
-1.0e+50
—
—
1.9e+00
9.9e-01
cases:1.68%
controls:0.82%
cases:1.09%
controls:0.24%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.77%
controls:0.12%
cases:1.95%
controls:0.73%
20
97
1174
11796
13
29
1181
11864
0
5
1194
11888
—
—
9
14
1162
11664
21
78
1058
10558
More than one and less than three hours
ZXE10 [2001311401]
6.1e-01
1.1e+00
1.7e+00
—
—
1.6e+00
1.0e+00
cases:6.37%
controls:3.56%
cases:3.35%
controls:1.18%
cases:0.42%
controls:0.08%
—
—
—
—
cases:4.01%
controls:0.80%
cases:7.97%
controls:3.00%
76
423
1118
11470
40
140
1154
11753
5
9
1189
11884
—
—
47
94
1124
11584
86
319
993
10317
General anesthesia, balanced
WX408 [2001310808]
5.1e-01
1.6e+00
—
—
—
1.7e+00
1.0e+00
cases:3.52%
controls:2.14%
cases:2.43%
controls:0.52%
—
—
—
—
—
—
cases:2.65%
controls:0.47%
cases:4.45%
controls:1.66%
42
254
1152
11639
29
62
1165
11831
—
—
—
31
55
1140
11623
48
177
1031
10459
INR in Blood by Coagulation assay
34714-6 [3032080]
2.6e-01
5.0e-01
7.2e-01
2.9e+00
6.5e-01
8.1e-01
5.7e-01
cases:5.78%
controls:4.52%
cases:4.19%
controls:2.59%
cases:1.17%
controls:0.57%
cases:1.09%
controls:0.06%
cases:1.17%
controls:0.61%
cases:4.61%
controls:2.10%
cases:9.73%
controls:5.76%
69
537
1125
11356
50
308
1144
11585
14
68
1180
11825
13
7
1181
11886
14
73
1180
11804
54
245
1117
11433
105
613
974
10023
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
5.7e-01
9.9e-01
—
—
1.5e+00
6.7e-01
5.3e-01
cases:8.54%
controls:4.99%
cases:3.52%
controls:1.34%
—
—
—
—
cases:0.75%
controls:0.17%
cases:2.82%
controls:1.46%
cases:6.95%
controls:4.22%
102
594
1092
11299
42
159
1152
11734
—
—
9
20
1185
11857
33
171
1138
11507
75
449
1004
10187
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.9e-01
3.7e-01
5.6e-01
2.9e+00
5.1e-01
4.1e-01
2.1e-01
cases:17.84%
controls:15.29%
cases:16.00%
controls:11.60%
cases:4.10%
controls:2.38%
cases:2.68%
controls:0.15%
cases:3.69%
controls:2.24%
cases:16.74%
controls:11.80%
cases:29.47%
controls:25.39%
213
1818
981
10075
191
1379
1003
10514
49
283
1145
11610
32
18
1162
11875
44
266
1150
11611
196
1378
975
10300
318
2701
761
7935
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
1.0e+00
—
—
—
—
2.5e+00
1.7e+00
cases:0.50%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.05%
cases:1.02%
controls:0.18%
6
22
1188
11871
—
—
—
—
7
6
1164
11672
11
19
1068
10617
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
1.0e+00
—
—
—
—
2.5e+00
1.7e+00
cases:0.50%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.05%
cases:1.02%
controls:0.18%
6
22
1188
11871
—
—
—
—
7
6
1164
11672
11
19
1068
10617
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
7.5e-01
7.6e-01
1.3e+00
—
1.9e+00
9.0e-01
6.3e-01
cases:4.94%
controls:2.39%
cases:1.76%
controls:0.83%
cases:0.42%
controls:0.12%
—
—
cases:0.67%
controls:0.10%
cases:1.79%
controls:0.74%
cases:6.12%
controls:3.36%
59
284
1135
11609
21
99
1173
11794
5
14
1189
11879
—
8
12
1186
11865
21
86
1150
11592
66
357
1013
10279
Fracture of lower end of radius
S52.5 [45573842]
5.4e-01
1.9e+00
—
—
2.3e+00
7.3e-01
6.1e-01
cases:1.17%
controls:0.69%
cases:1.17%
controls:0.18%
—
—
—
—
cases:0.50%
controls:0.05%
cases:0.43%
controls:0.21%
cases:1.48%
controls:0.81%
14
82
1180
11811
14
22
1180
11871
—
—
6
6
1188
11871
5
24
1166
11654
16
86
1063
10550
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.7e-01
8.9e-01
—
—
1.8e+00
8.9e-01
5.8e-01
cases:4.27%
controls:3.00%
cases:3.35%
controls:1.40%
—
—
—
—
cases:0.59%
controls:0.10%
cases:2.39%
controls:0.99%
cases:6.02%
controls:3.47%
51
357
1143
11536
40
167
1154
11726
—
—
7
12
1187
11865
28
116
1143
11562
65
369
1014
10267
FEV1/FVC
19926-5 [3011505]
1.3e+00
7.2e-01
—
—
—
1.2e+00
1.6e+00
cases:3.35%
controls:0.96%
cases:0.67%
controls:0.33%
—
—
—
—
—
—
cases:1.02%
controls:0.31%
cases:2.97%
controls:0.60%
40
114
1154
11779
8
39
1186
11854
—
—
—
12
36
1159
11642
32
64
1047
10572
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.3e+00
7.2e-01
—
—
—
1.2e+00
1.6e+00
cases:3.35%
controls:0.96%
cases:0.67%
controls:0.33%
—
—
—
—
—
—
cases:1.02%
controls:0.31%
cases:2.97%
controls:0.60%
40
114
1154
11779
8
39
1186
11854
—
—
—
12
36
1159
11642
32
64
1047
10572
FEV1
20150-9 [3024653]
1.3e+00
7.2e-01
—
—
—
1.2e+00
1.6e+00
cases:3.35%
controls:0.96%
cases:0.67%
controls:0.33%
—
—
—
—
—
—
cases:1.02%
controls:0.31%
cases:2.97%
controls:0.60%
40
114
1154
11779
8
39
1186
11854
—
—
—
12
36
1159
11642
32
64
1047
10572
Fall on same level involving ice and snow
W00 [45756242]
8.2e-01
1.4e+00
2.6e+00
—
—
9.2e-01
4.4e-01
cases:1.59%
controls:0.71%
cases:1.01%
controls:0.24%
cases:0.59%
controls:0.04%
—
—
—
—
cases:0.60%
controls:0.24%
cases:1.48%
controls:0.96%
19
84
1175
11809
12
29
1182
11864
7
5
1187
11888
—
—
7
28
1164
11650
16
102
1063
10534
celecoxib
L01XX33 [21603805]
7.4e-01
1.3e+00
—
—
2.0e+00
1.3e+00
7.2e-01
cases:3.27%
controls:1.58%
cases:2.09%
controls:0.60%
—
—
—
—
cases:0.42%
controls:0.06%
cases:1.88%
controls:0.51%
cases:3.43%
controls:1.70%
39
188
1155
11705
25
71
1169
11822
—
—
5
7
1189
11870
22
59
1149
11619
37
181
1042
10455
celecoxib; oral
M01AH01 [21603992]
7.4e-01
1.3e+00
—
—
2.0e+00
1.3e+00
7.2e-01
cases:3.27%
controls:1.58%
cases:2.09%
controls:0.60%
—
—
—
—
cases:0.42%
controls:0.06%
cases:1.88%
controls:0.51%
cases:3.43%
controls:1.70%
39
188
1155
11705
25
71
1169
11822
—
—
5
7
1189
11870
22
59
1149
11619
37
181
1042
10455
tizanidine; oral
M03BX02 [21604116]
6.8e-01
1.0e+00
9.2e-01
—
1.2e+00
5.4e-01
5.9e-01
cases:21.61%
controls:12.24%
cases:10.39%
controls:4.05%
cases:1.17%
controls:0.47%
—
—
cases:1.59%
controls:0.47%
cases:7.09%
controls:4.25%
cases:21.32%
controls:13.02%
258
1456
936
10437
124
482
1070
11411
14
56
1180
11837
—
19
56
1175
11821
83
496
1088
11182
230
1385
849
9251
Other dorsalgia
M54.8 [45538790]
1.7e+00
2.3e+00
—
—
—
—
6.3e-01
cases:1.01%
controls:0.18%
cases:0.50%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.35%
12
22
1182
11871
6
6
1188
11887
—
—
—
—
7
37
1072
10599
Pulmonary Disease
29 [38004472]
5.6e-01
7.6e-01
1.1e+00
—
9.4e-01
6.4e-01
8.4e-01
cases:9.30%
controls:5.55%
cases:5.61%
controls:2.71%
cases:1.51%
controls:0.50%
—
—
cases:1.26%
controls:0.50%
cases:5.47%
controls:2.96%
cases:13.44%
controls:6.25%
111
660
1083
11233
67
322
1127
11571
18
59
1176
11834
—
15
59
1179
11818
64
346
1107
11332
145
665
934
9971
Radial styloid tenosynovitis [de Quervain]
M65.4 [45553231]
1.6e+00
2.3e+00
—
—
—
2.3e+00
1.5e+00
cases:0.67%
controls:0.13%
cases:0.42%
controls:0.04%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.65%
controls:0.15%
8
16
1186
11877
5
5
1189
11888
—
—
—
6
6
1165
11672
7
16
1072
10620
piroxicam; ointment
M02AA07 [21604043]
7.6e-01
1.2e+00
—
—
—
1.1e+00
8.3e-01
cases:7.79%
controls:3.82%
cases:2.85%
controls:0.88%
—
—
—
—
—
—
cases:2.90%
controls:0.95%
cases:6.86%
controls:3.12%
93
454
1101
11439
34
105
1160
11788
—
—
—
34
111
1137
11567
74
332
1005
10304
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
—
—
—
—
—
2.3e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.93%
controls:0.19%
—
—
—
—
—
6
6
1165
11672
10
20
1069
10616
prednisolone; oral, parenteral
H02AB06 [21602734]
6.0e-01
8.2e-01
9.0e-01
—
9.6e-01
7.5e-01
7.8e-01
cases:11.39%
controls:6.61%
cases:6.03%
controls:2.76%
cases:1.09%
controls:0.45%
—
—
cases:1.42%
controls:0.55%
cases:5.72%
controls:2.80%
cases:15.11%
controls:7.56%
136
786
1058
11107
72
328
1122
11565
13
53
1181
11840
—
17
65
1177
11812
67
327
1104
11351
163
804
916
9832
Back symptom/complaint
L02 [2002000627]
1.3e+00
1.5e+00
—
—
—
1.5e+00
1.1e+00
cases:1.84%
controls:0.50%
cases:0.92%
controls:0.21%
—
—
—
—
—
—
cases:0.68%
controls:0.15%
cases:2.04%
controls:0.69%
22
60
1172
11833
11
25
1183
11868
—
—
—
8
18
1163
11660
22
73
1057
10563
Supplier / Service Provider
OMOP5117446 [33004]
-8.7e-01
-1.1e+00
—
-1.0e+50
—
2.5e+00
3.3e+00
cases:12.81%
controls:26.03%
cases:3.18%
controls:8.84%
—
—
cases:0.00%
controls:0.06%
—
—
cases:3.67%
controls:0.31%
cases:14.55%
controls:0.60%
153
3096
1041
8797
38
1051
1156
10842
—
0
7
1194
11886
—
43
36
1128
11642
157
64
922
10572
prednisolone
A07EA01 [21600653]
6.0e-01
8.2e-01
9.0e-01
—
9.6e-01
7.4e-01
7.7e-01
cases:11.47%
controls:6.64%
cases:6.03%
controls:2.76%
cases:1.09%
controls:0.45%
—
—
cases:1.42%
controls:0.55%
cases:5.72%
controls:2.83%
cases:15.11%
controls:7.61%
137
790
1057
11103
72
328
1122
11565
13
53
1181
11840
—
17
65
1177
11812
67
330
1104
11348
163
809
916
9827
carisoprodol; oral
M03BA02 [21604094]
1.7e+00
1.4e+00
—
—
—
2.2e+00
1.3e+00
cases:1.26%
controls:0.24%
cases:0.42%
controls:0.10%
—
—
—
—
—
—
cases:0.68%
controls:0.08%
cases:0.74%
controls:0.21%
15
28
1179
11865
5
12
1189
11881
—
—
—
8
9
1163
11669
8
22
1071
10614
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
9.6e-01
7.3e-01
—
—
—
1.5e+00
1.4e+00
cases:1.51%
controls:0.58%
cases:0.50%
controls:0.24%
—
—
—
—
—
—
cases:0.85%
controls:0.20%
cases:2.50%
controls:0.61%
18
69
1176
11824
6
29
1188
11864
—
—
—
10
23
1161
11655
27
65
1052
10571
Acromioplastia, arthroscopic
NBG15 [2001307302]
1.4e+00
1.7e+00
—
1.0e+50
—
2.4e+00
8.2e-01
cases:1.76%
controls:0.43%
cases:0.42%
controls:0.08%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.85%
controls:0.08%
cases:1.20%
controls:0.54%
21
51
1173
11842
5
9
1189
11884
—
5
0
1189
11893
—
10
9
1161
11669
13
57
1066
10579
baclofen; oral, parenteral
M03BX01 [21604115]
1.0e+00
1.9e+00
—
—
—
—
1.9e+00
cases:0.50%
controls:0.18%
cases:0.59%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.11%
6
21
1188
11872
7
10
1187
11883
—
—
—
—
8
12
1071
10624
Predominantly allergic asthma
J45.0 [45557624]
1.3e+00
1.3e+00
—
—
1.8e+00
9.2e-01
1.3e+00
cases:3.10%
controls:0.89%
cases:1.34%
controls:0.39%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.02%
controls:0.41%
cases:2.87%
controls:0.79%
37
106
1157
11787
16
46
1178
11847
—
—
6
10
1188
11867
12
48
1159
11630
31
84
1048
10552
rofecoxib; oral
M01AH02 [21603993]
1.1e+00
1.6e+00
—
—
—
1.1e+00
1.1e+00
cases:2.68%
controls:0.95%
cases:1.42%
controls:0.29%
—
—
—
—
—
—
cases:0.60%
controls:0.21%
cases:2.13%
controls:0.69%
32
113
1162
11780
17
34
1177
11859
—
—
—
7
24
1164
11654
23
73
1056
10563
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
7.5e-01
9.6e-01
1.5e+00
—
1.2e+00
1.3e+00
7.5e-01
cases:4.19%
controls:2.02%
cases:2.18%
controls:0.85%
cases:0.59%
controls:0.13%
—
—
cases:0.67%
controls:0.19%
cases:2.82%
controls:0.75%
cases:5.47%
controls:2.66%
50
240
1144
11653
26
101
1168
11792
7
15
1187
11878
—
8
23
1186
11854
33
88
1138
11590
59
283
1020
10353
One hour or less
ZXE00 [2001311394]
4.3e-01
9.2e-01
1.5e+00
—
1.1e+00
1.5e+00
9.0e-01
cases:6.95%
controls:4.62%
cases:3.43%
controls:1.40%
cases:0.59%
controls:0.13%
—
—
cases:0.59%
controls:0.19%
cases:4.27%
controls:0.97%
cases:8.53%
controls:3.65%
83
550
1111
11343
41
166
1153
11727
7
16
1187
11877
—
7
23
1187
11854
50
113
1121
11565
92
388
987
10248
Chronic alcohol abuse
P15 [2002000811]
1.6e+00
2.1e+00
—
—
—
—
1.2e+00
cases:0.75%
controls:0.15%
cases:0.50%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.25%
9
18
1185
11875
6
7
1188
11886
—
—
—
—
9
27
1070
10609
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
8.2e-01
1.2e+00
—
—
—
1.1e+00
6.7e-01
cases:9.55%
controls:4.45%
cases:3.35%
controls:1.06%
—
—
—
—
—
—
cases:3.25%
controls:1.11%
cases:7.04%
controls:3.73%
114
529
1080
11364
40
126
1154
11767
—
—
—
38
130
1133
11548
76
397
1003
10239
pH of Serum or Plasma
2753-2 [3018418]
5.8e-01
5.8e-01
1.5e+00
—
8.2e-01
8.1e-01
8.5e-01
cases:4.19%
controls:2.40%
cases:2.35%
controls:1.33%
cases:0.75%
controls:0.17%
—
—
cases:0.42%
controls:0.19%
cases:2.90%
controls:1.32%
cases:7.51%
controls:3.34%
50
285
1144
11608
28
158
1166
11735
9
20
1185
11873
—
5
22
1189
11855
34
154
1137
11524
81
355
998
10281
androstanolone
A14AA01 [21600917]
1.3e+00
1.3e+00
—
—
1.6e+00
1.0e+00
1.2e+00
cases:1.17%
controls:0.34%
cases:1.09%
controls:0.29%
—
—
—
—
cases:0.50%
controls:0.10%
cases:0.85%
controls:0.32%
cases:1.48%
controls:0.47%
14
40
1180
11853
13
35
1181
11858
—
—
6
12
1188
11865
10
37
1161
11641
16
50
1063
10586
androstanolone
G03BB02 [21602513]
1.3e+00
1.3e+00
—
—
1.6e+00
1.1e+00
1.2e+00
cases:1.17%
controls:0.33%
cases:1.01%
controls:0.29%
—
—
—
—
cases:0.50%
controls:0.10%
cases:0.85%
controls:0.29%
cases:1.39%
controls:0.43%
14
39
1180
11854
12
34
1182
11859
—
—
6
12
1188
11865
10
34
1161
11644
15
46
1064
10590
Medial epicondylitis
M77.0 [45557989]
1.9e+00
—
—
1.0e+50
—
—
1.8e+00
cases:0.67%
controls:0.10%
—
—
—
—
cases:0.42%
controls:0.00%
—
—
—
—
cases:0.74%
controls:0.12%
8
12
1186
11881
—
—
5
0
1189
11893
—
—
8
13
1071
10623
Epilepsy, unspecified
G40.9 [45562083]
6.0e-01
1.9e+00
—
—
—
1.9e+00
1.1e+00
cases:0.50%
controls:0.28%
cases:0.59%
controls:0.09%
—
—
—
—
—
—
cases:0.60%
controls:0.09%
cases:0.93%
controls:0.31%
6
33
1188
11860
7
11
1187
11882
—
—
—
7
11
1164
11667
10
33
1069
10603
Pain localized to other parts of lower abdomen
R10.3 [45534426]
9.1e-01
1.1e+00
—
—
—
9.9e-01
6.4e-01
cases:4.77%
controls:1.98%
cases:1.68%
controls:0.55%
—
—
—
—
—
—
cases:1.62%
controls:0.61%
cases:4.36%
controls:2.34%
57
236
1137
11657
20
66
1174
11827
—
—
—
19
71
1152
11607
47
249
1032
10387
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.9e-01
6.6e-01
1.2e+00
—
8.7e-01
7.3e-01
6.2e-01
cases:6.78%
controls:4.26%
cases:4.44%
controls:2.35%
cases:1.09%
controls:0.34%
—
—
cases:0.84%
controls:0.35%
cases:4.78%
controls:2.37%
cases:11.12%
controls:6.30%
81
507
1113
11386
53
279
1141
11614
13
41
1181
11852
—
10
42
1184
11835
56
277
1115
11401
120
670
959
9966
Asthma, unspecified
J45.9 [45562456]
1.1e+00
9.2e-01
—
1.0e+50
—
9.1e-01
7.3e-01
cases:4.52%
controls:1.62%
cases:1.76%
controls:0.71%
—
—
cases:0.42%
controls:0.00%
—
—
cases:1.96%
controls:0.80%
cases:5.00%
controls:2.48%
54
193
1140
11700
21
84
1173
11809
—
5
0
1189
11893
—
23
93
1148
11585
54
264
1025
10372
Respiratory and circulatory monitoring
WX700 [2001310817]
3.6e-01
1.4e+00
—
—
—
1.4e+00
8.1e-01
cases:1.68%
controls:1.18%
cases:1.51%
controls:0.38%
—
—
—
—
—
—
cases:1.11%
controls:0.27%
cases:2.69%
controls:1.21%
20
140
1174
11753
18
45
1176
11848
—
—
—
13
32
1158
11646
29
129
1050
10507
temazepam; oral
N05CD07 [21604642]
6.8e-01
1.1e+00
1.1e+00
—
1.0e+00
9.0e-01
9.7e-01
cases:4.19%
controls:2.16%
cases:3.18%
controls:1.14%
cases:0.84%
controls:0.27%
—
—
cases:0.84%
controls:0.29%
cases:2.99%
controls:1.23%
cases:5.93%
controls:2.34%
50
257
1144
11636
38
135
1156
11758
10
32
1184
11861
—
10
35
1184
11842
35
144
1136
11534
64
249
1015
10387
Laboratory Visit
OMOP4822461 [32036]
7.1e-02
1.9e-01
5.4e-01
2.2e+00
5.2e-01
2.9e-01
1.5e-01
cases:24.87%
controls:23.58%
cases:25.21%
controls:21.84%
cases:10.13%
controls:6.18%
cases:3.69%
controls:0.40%
cases:9.88%
controls:6.11%
cases:28.61%
controls:23.01%
cases:41.33%
controls:37.76%
297
2804
897
9089
301
2597
893
9296
121
735
1073
11158
44
48
1150
11845
118
726
1076
11151
335
2687
836
8991
446
4016
633
6620
Fibromyalgia
M79.7 [45553272]
1.8e+00
—
—
—
—
1.7e+00
1.8e+00
cases:0.84%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.08%
cases:1.48%
controls:0.24%
10
17
1184
11876
—
—
—
—
5
9
1166
11669
16
26
1063
10610
Emergency Medicine
93 [38004510]
3.6e-01
5.1e-01
1.4e+00
—
8.3e-01
7.4e-01
5.9e-01
cases:10.30%
controls:7.41%
cases:6.53%
controls:4.04%
cases:1.51%
controls:0.39%
—
—
cases:1.17%
controls:0.51%
cases:7.51%
controls:3.72%
cases:18.63%
controls:11.24%
123
881
1071
11012
78
480
1116
11413
18
46
1176
11847
—
14
61
1180
11816
88
434
1083
11244
201
1196
878
9440
clindamycin; oral, parenteral
J01FF01 [21602985]
6.7e-01
9.2e-01
—
—
—
1.0e+00
9.1e-01
cases:5.03%
controls:2.63%
cases:1.51%
controls:0.61%
—
—
—
—
—
—
cases:2.05%
controls:0.74%
cases:5.75%
controls:2.40%
60
313
1134
11580
18
72
1176
11821
—
—
—
24
86
1147
11592
62
255
1017
10381
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
9.5e-01
1.0e+00
—
—
8.2e-01
7.0e-01
8.6e-01
cases:12.73%
controls:5.33%
cases:4.94%
controls:1.84%
—
—
—
—
cases:0.42%
controls:0.19%
cases:3.67%
controls:1.85%
cases:12.51%
controls:5.73%
152
634
1042
11259
59
219
1135
11674
—
—
5
22
1189
11855
43
216
1128
11462
135
609
944
10027
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
9.5e-01
1.0e+00
—
—
8.2e-01
7.0e-01
8.6e-01
cases:12.73%
controls:5.33%
cases:4.94%
controls:1.84%
—
—
—
—
cases:0.42%
controls:0.19%
cases:3.67%
controls:1.85%
cases:12.51%
controls:5.73%
152
634
1042
11259
59
219
1135
11674
—
—
5
22
1189
11855
43
216
1128
11462
135
609
944
10027
Lumbago with sciatica
M54.4 [45553205]
7.8e-01
8.6e-01
—
—
—
1.6e+00
1.1e+00
cases:2.60%
controls:1.21%
cases:1.01%
controls:0.43%
—
—
—
—
—
—
cases:2.05%
controls:0.41%
cases:5.28%
controls:1.79%
31
144
1163
11749
12
51
1182
11842
—
—
—
24
48
1147
11630
57
190
1022
10446
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.3e-01
7.2e-01
7.5e-01
—
3.4e-01
6.4e-01
7.3e-01
cases:17.67%
controls:10.22%
cases:10.80%
controls:5.57%
cases:2.09%
controls:1.00%
—
—
cases:1.51%
controls:1.08%
cases:10.42%
controls:5.75%
cases:23.82%
controls:13.13%
211
1216
983
10677
129
663
1065
11230
25
119
1169
11774
—
18
128
1176
11749
122
672
1049
11006
257
1396
822
9240
Pain general/multiple sites
A01 [2002000142]
1.4e+00
2.1e+00
—
—
—
1.4e+00
9.1e-01
cases:1.17%
controls:0.29%
cases:0.67%
controls:0.08%
—
—
—
—
—
—
cases:0.68%
controls:0.17%
cases:1.58%
controls:0.64%
14
35
1180
11858
8
10
1186
11883
—
—
—
8
20
1163
11658
17
68
1062
10568
Low back pain
M54.5 [45553207]
1.1e+00
7.4e-01
1.1e+00
—
—
8.6e-01
8.0e-01
cases:7.96%
controls:2.90%
cases:2.76%
controls:1.34%
cases:0.50%
controls:0.17%
—
—
—
—
cases:3.07%
controls:1.33%
cases:9.55%
controls:4.51%
95
345
1099
11548
33
159
1161
11734
6
20
1188
11873
—
—
36
155
1135
11523
103
480
976
10156
Other and unspecified abdominal pain
R10.4 [45568113]
1.0e+00
7.9e-01
1.2e+00
—
—
9.1e-01
7.1e-01
cases:9.80%
controls:3.79%
cases:2.68%
controls:1.24%
cases:0.42%
controls:0.13%
—
—
—
—
cases:2.90%
controls:1.19%
cases:7.69%
controls:3.92%
117
451
1077
11442
32
147
1162
11746
5
15
1189
11878
—
—
34
139
1137
11539
83
417
996
10219
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
1.1e+00
1.0e+00
—
—
1.1e+00
9.0e-01
1.3e+00
cases:1.59%
controls:0.54%
cases:1.17%
controls:0.42%
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.02%
controls:0.42%
cases:2.22%
controls:0.64%
19
64
1175
11829
14
50
1180
11843
—
—
6
19
1188
11858
12
49
1159
11629
24
68
1055
10568
nimesulide; oral
M01AX17 [21604007]
8.6e-01
1.5e+00
—
—
—
1.0e+00
3.4e-01
cases:4.69%
controls:2.04%
cases:1.51%
controls:0.34%
—
—
—
—
—
—
cases:1.20%
controls:0.43%
cases:1.85%
controls:1.33%
56
243
1138
11650
18
41
1176
11852
—
—
—
14
50
1157
11628
20
141
1059
10495
Lesion of ulnar nerve
G56.2 [45595951]
3.4e+00
—
1.0e+50
1.0e+50
1.0e+50
—
—
cases:1.42%
controls:0.05%
—
—
cases:0.75%
controls:0.00%
cases:0.84%
controls:0.00%
cases:1.26%
controls:0.00%
—
—
—
—
17
6
1177
11887
—
9
0
1185
11893
10
0
1184
11893
15
0
1179
11877
—
—
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
3.7e-01
1.3e+00
—
—
—
1.1e+00
9.3e-01
cases:1.84%
controls:1.28%
cases:1.76%
controls:0.50%
—
—
—
—
—
—
cases:1.28%
controls:0.42%
cases:3.61%
controls:1.46%
22
152
1172
11741
21
60
1173
11833
—
—
—
15
49
1156
11629
39
155
1040
10481
Other and unspecified convulsions
R56.8 [45602033]
5.6e-01
2.0e+00
—
—
—
1.4e+00
1.2e+00
cases:0.84%
controls:0.48%
cases:1.09%
controls:0.14%
—
—
—
—
—
—
cases:0.43%
controls:0.10%
cases:1.39%
controls:0.41%
10
57
1184
11836
13
17
1181
11876
—
—
—
5
12
1166
11666
15
44
1064
10592
Sciatica
M54.3 [45586994]
1.3e+00
—
—
—
—
—
1.9e+00
cases:1.17%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.31%
14
38
1180
11855
—
—
—
—
—
23
33
1056
10603
omeprazole; oral, parenteral
A02BC01 [21600096]
7.3e-01
8.7e-01
—
—
8.6e-01
8.0e-01
8.5e-01
cases:6.11%
controls:3.05%
cases:3.18%
controls:1.35%
—
—
—
—
cases:0.75%
controls:0.32%
cases:2.99%
controls:1.37%
cases:7.14%
controls:3.17%
73
363
1121
11530
38
161
1156
11732
—
—
9
38
1185
11839
35
160
1136
11518
77
337
1002
10299
citalopram; oral, parenteral
N06AB04 [21604712]
7.6e-01
7.9e-01
2.4e-01
—
1.2e+00
8.0e-01
8.9e-01
cases:5.44%
controls:2.62%
cases:3.18%
controls:1.47%
cases:0.50%
controls:0.40%
—
—
cases:1.01%
controls:0.32%
cases:3.33%
controls:1.52%
cases:6.49%
controls:2.77%
65
312
1129
11581
38
175
1156
11718
6
47
1188
11846
—
12
38
1182
11839
39
178
1132
11500
70
295
1009
10341
Osmolality of Urine
2695-5 [3026782]
6.7e-01
8.4e-01
—
—
1.9e+00
9.5e-01
7.7e-01
cases:3.43%
controls:1.78%
cases:1.76%
controls:0.77%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.71%
controls:0.67%
cases:4.36%
controls:2.07%
41
212
1153
11681
21
91
1173
11802
—
—
6
9
1188
11868
20
78
1151
11600
47
220
1032
10416
Depressive episode, unspecified
F32.9 [45571760]
7.7e-01
1.4e+00
—
—
—
5.5e-01
1.1e+00
cases:2.35%
controls:1.10%
cases:1.51%
controls:0.40%
—
—
—
—
—
—
cases:0.68%
controls:0.39%
cases:3.80%
controls:1.32%
28
131
1166
11762
18
47
1176
11846
—
—
—
8
46
1163
11632
41
140
1038
10496
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
7.7e-01
7.5e-01
—
—
1.5e+00
8.7e-01
8.0e-01
cases:4.77%
controls:2.27%
cases:2.43%
controls:1.16%
—
—
—
—
cases:0.59%
controls:0.13%
cases:2.65%
controls:1.12%
cases:6.49%
controls:3.04%
57
270
1137
11623
29
138
1165
11755
—
—
7
16
1187
11861
31
131
1140
11547
70
323
1009
10313
Brachial plexus disorders
G54.0 [45586302]
3.2e+00
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
cases:1.01%
controls:0.04%
—
—
cases:0.59%
controls:0.00%
cases:0.75%
controls:0.00%
cases:0.67%
controls:0.00%
cases:2.39%
controls:0.00%
—
—
12
5
1182
11888
—
7
0
1187
11893
9
0
1185
11893
8
0
1186
11877
28
0
1143
11678
—
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
3.8e-01
8.0e-01
—
—
—
1.6e+00
1.6e+00
cases:0.50%
controls:0.34%
cases:0.50%
controls:0.23%
—
—
—
—
—
—
cases:0.85%
controls:0.17%
cases:1.20%
controls:0.25%
6
41
1188
11852
6
27
1188
11866
—
—
—
10
20
1161
11658
13
27
1066
10609
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
-8.1e-02
1.6e+00
—
—
—
1.5e+00
6.2e-01
cases:0.42%
controls:0.45%
cases:0.75%
controls:0.15%
—
—
—
—
—
—
cases:0.85%
controls:0.19%
cases:1.30%
controls:0.71%
5
54
1189
11839
9
18
1185
11875
—
—
—
10
22
1161
11656
14
75
1065
10561
oxcarbazepine; oral
N03AF02 [21604418]
1.0e+00
1.2e+00
—
—
—
1.6e+00
1.5e+00
cases:0.84%
controls:0.30%
cases:0.84%
controls:0.25%
—
—
—
—
—
—
cases:1.20%
controls:0.24%
cases:1.48%
controls:0.34%
10
36
1184
11857
10
30
1184
11863
—
—
—
14
28
1157
11650
16
36
1063
10600
Wrist symptom/complaint
L11 [2002000635]
5.1e-01
1.8e+00
—
—
—
6.9e-01
1.3e+00
cases:0.75%
controls:0.45%
cases:0.84%
controls:0.14%
—
—
—
—
—
—
cases:0.51%
controls:0.26%
cases:1.85%
controls:0.50%
9
54
1185
11839
10
17
1184
11876
—
—
—
6
30
1165
11648
20
53
1059
10583
lansoprazole; oral
A02BC03 [21600098]
7.1e-01
8.0e-01
6.5e-01
—
8.9e-01
8.9e-01
7.1e-01
cases:7.20%
controls:3.67%
cases:3.94%
controls:1.81%
cases:0.84%
controls:0.44%
—
—
cases:0.84%
controls:0.35%
cases:4.27%
controls:1.81%
cases:8.25%
controls:4.25%
86
437
1108
11456
47
215
1147
11678
10
52
1184
11841
—
10
41
1184
11836
50
211
1121
11467
89
452
990
10184
oxycodone and naloxone; oral
N02AA55 [21604265]
1.1e+00
1.1e+00
—
—
2.0e+00
1.2e+00
7.4e-01
cases:2.09%
controls:0.70%
cases:1.01%
controls:0.33%
—
—
—
—
cases:0.42%
controls:0.06%
cases:1.28%
controls:0.38%
cases:2.87%
controls:1.39%
25
83
1169
11810
12
39
1182
11854
—
—
5
7
1189
11870
15
44
1156
11634
31
148
1048
10488
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
7.2e-01
7.7e-01
5.8e-01
—
1.4e+00
8.1e-01
7.8e-01
cases:5.19%
controls:2.60%
cases:2.76%
controls:1.30%
cases:0.42%
controls:0.24%
—
—
cases:0.59%
controls:0.15%
cases:2.99%
controls:1.35%
cases:7.88%
controls:3.78%
62
309
1132
11584
33
155
1161
11738
5
28
1189
11865
—
7
18
1187
11859
35
158
1136
11520
85
402
994
10234
Pain localized to upper abdomen
R10.1 [45568111]
8.8e-01
1.4e+00
—
—
—
5.9e-02
7.4e-01
cases:2.43%
controls:1.03%
cases:1.42%
controls:0.34%
—
—
—
—
—
—
cases:0.43%
controls:0.40%
cases:3.24%
controls:1.57%
29
122
1165
11771
17
41
1177
11852
—
—
—
5
47
1166
11631
35
167
1044
10469
Thorax X-ray examination
GD1AA [2001303617]
5.0e-01
8.3e-01
—
—
—
8.9e-01
8.0e-01
cases:6.53%
controls:4.08%
cases:3.52%
controls:1.56%
—
—
—
—
—
—
cases:3.50%
controls:1.46%
cases:10.01%
controls:4.77%
78
485
1116
11408
42
186
1152
11707
—
—
—
41
171
1130
11507
108
507
971
10129
Hypersensitivity skin testing
268377001 [4147813]
5.1e-01
1.2e+00
—
—
—
1.9e+00
1.1e+00
cases:1.34%
controls:0.81%
cases:0.59%
controls:0.18%
—
—
—
—
—
—
cases:0.77%
controls:0.11%
cases:1.76%
controls:0.61%
16
96
1178
11797
7
21
1187
11872
—
—
—
9
13
1162
11665
19
65
1060
10571
Inpatient Visit
IP [9201]
5.1e-01
8.0e-01
—
—
1.4e+00
1.2e+00
4.6e-01
cases:9.46%
controls:5.89%
cases:4.69%
controls:2.17%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.47%
controls:1.67%
cases:7.23%
controls:4.70%
113
700
1081
11193
56
258
1138
11635
—
—
9
23
1185
11854
64
195
1107
11483
78
500
1001
10136
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
8.5e-01
1.0e-01
—
—
—
1.1e+00
1.1e+00
cases:3.52%
controls:1.54%
cases:0.67%
controls:0.61%
—
—
—
—
—
—
cases:1.62%
controls:0.56%
cases:4.73%
controls:1.69%
42
183
1152
11710
8
72
1186
11821
—
—
—
19
65
1152
11613
51
180
1028
10456
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
6.9e-01
7.3e-01
—
—
1.3e+00
7.9e-01
7.8e-01
cases:6.28%
controls:3.25%
cases:3.10%
controls:1.52%
—
—
—
—
cases:0.67%
controls:0.19%
cases:3.07%
controls:1.42%
cases:9.08%
controls:4.38%
75
387
1119
11506
37
181
1157
11712
—
—
8
22
1186
11855
36
166
1135
11512
98
466
981
10170
tamsulosin; oral
G04CA02 [21602669]
6.0e-01
7.6e-01
5.5e-01
—
1.1e+00
7.7e-01
8.5e-01
cases:3.85%
controls:2.14%
cases:2.93%
controls:1.40%
cases:0.75%
controls:0.44%
—
—
cases:0.84%
controls:0.29%
cases:3.25%
controls:1.52%
cases:7.04%
controls:3.15%
46
255
1148
11638
35
166
1159
11727
9
52
1185
11841
—
10
34
1184
11843
38
178
1133
11500
76
335
1003
10301
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
8.0e-01
1.3e+00
—
1.0e+50
—
1.1e+00
8.6e-01
cases:1.84%
controls:0.83%
cases:1.42%
controls:0.39%
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.94%
controls:0.33%
cases:3.06%
controls:1.32%
22
99
1172
11794
17
46
1177
11847
—
6
0
1188
11893
—
11
38
1160
11640
33
140
1046
10496
naproxen; oral, rectal
M01AE02 [21603968]
6.7e-01
1.0e+00
9.0e-01
—
9.1e-01
6.2e-01
6.6e-01
cases:15.75%
controls:8.70%
cases:7.29%
controls:2.78%
cases:1.01%
controls:0.41%
—
—
cases:0.67%
controls:0.27%
cases:5.72%
controls:3.15%
cases:14.64%
controls:8.14%
188
1035
1006
10858
87
331
1107
11562
12
49
1182
11844
—
8
32
1186
11845
67
368
1104
11310
158
866
921
9770
naproxcinod
M01AE18 [40254094]
6.7e-01
1.0e+00
9.0e-01
—
9.1e-01
6.2e-01
6.6e-01
cases:15.75%
controls:8.70%
cases:7.29%
controls:2.78%
cases:1.01%
controls:0.41%
—
—
cases:0.67%
controls:0.27%
cases:5.72%
controls:3.15%
cases:14.64%
controls:8.14%
188
1035
1006
10858
87
331
1107
11562
12
49
1182
11844
—
8
32
1186
11845
67
368
1104
11310
158
866
921
9770
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
6.8e-01
1.4e+00
—
—
—
9.0e-01
9.1e-01
cases:3.10%
controls:1.60%
cases:1.59%
controls:0.41%
—
—
—
—
—
—
cases:1.28%
controls:0.52%
cases:5.00%
controls:2.08%
37
190
1157
11703
19
49
1175
11844
—
—
—
15
61
1156
11617
54
221
1025
10415
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.0e+00
1.9e+00
—
—
—
1.2e+00
7.1e-01
cases:1.76%
controls:0.66%
cases:1.26%
controls:0.18%
—
—
—
—
—
—
cases:0.77%
controls:0.23%
cases:1.85%
controls:0.92%
21
78
1173
11815
15
22
1179
11871
—
—
—
9
27
1162
11651
20
98
1059
10538
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
G55.1*M51.1 [2000502168]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.05%
—
—
—
—
—
—
9
5
1070
10631
Medical doctor
Z2221 [2001311556]
4.6e-01
8.6e-01
—
—
—
8.9e-01
6.4e-01
cases:5.53%
controls:3.55%
cases:2.60%
controls:1.11%
—
—
—
—
—
—
cases:2.48%
controls:1.03%
cases:5.28%
controls:2.87%
66
422
1128
11471
31
132
1163
11761
—
—
—
29
120
1142
11558
57
305
1022
10331
Dentistry
C5 [903277]
5.7e-01
1.1e+00
1.4e+00
—
1.7e+00
1.0e+00
7.2e-01
cases:2.76%
controls:1.59%
cases:1.34%
controls:0.45%
cases:0.42%
controls:0.10%
—
—
cases:0.50%
controls:0.09%
cases:1.45%
controls:0.54%
cases:3.52%
controls:1.74%
33
189
1161
11704
16
53
1178
11840
5
12
1189
11881
—
6
11
1188
11866
17
63
1154
11615
38
185
1041
10451
Chest pain, unspecified
R07.4 [45558450]
8.3e-01
5.1e-01
—
—
—
1.1e+00
8.8e-01
cases:4.77%
controls:2.14%
cases:1.09%
controls:0.66%
—
—
—
—
—
—
cases:2.31%
controls:0.78%
cases:6.58%
controls:2.83%
57
255
1137
11638
13
78
1181
11815
—
—
—
27
91
1144
11587
71
301
1008
10335
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.7e-01
7.9e-01
3.8e-01
—
1.1e+00
7.4e-01
7.1e-01
cases:5.19%
controls:3.02%
cases:3.35%
controls:1.55%
cases:0.42%
controls:0.29%
—
—
cases:0.67%
controls:0.23%
cases:3.50%
controls:1.70%
cases:8.80%
controls:4.55%
62
359
1132
11534
40
184
1154
11709
5
34
1189
11859
—
8
27
1186
11850
41
199
1130
11479
95
484
984
10152
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.6e-01
1.2e+00
—
—
—
6.7e-01
8.2e-01
cases:2.51%
controls:1.19%
cases:1.84%
controls:0.55%
—
—
—
—
—
—
cases:1.20%
controls:0.62%
cases:3.52%
controls:1.59%
30
141
1164
11752
22
66
1172
11827
—
—
—
14
72
1157
11606
38
169
1041
10467
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.8e-01
5.7e-01
5.8e-01
-1.0e+50
7.9e-01
5.3e-01
5.1e-01
cases:13.07%
controls:9.29%
cases:9.55%
controls:5.62%
cases:1.93%
controls:1.09%
cases:0.00%
controls:0.06%
cases:2.26%
controls:1.04%
cases:9.48%
controls:5.83%
cases:20.57%
controls:13.42%
156
1105
1038
10788
114
668
1080
11225
23
130
1171
11763
0
7
1194
11886
27
124
1167
11753
111
681
1060
10997
222
1427
857
9209
Cerebrospinal fluid IgG ratio and IgG index
1324000 [4027681]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.05%
—
—
—
—
—
—
8
5
1071
10631
Intravenous general anesthesia
WX404 [2001310807]
3.9e-01
2.1e-01
—
—
—
1.6e+00
1.2e+00
cases:2.60%
controls:1.77%
cases:0.75%
controls:0.61%
—
—
—
—
—
—
cases:1.79%
controls:0.38%
cases:3.89%
controls:1.24%
31
211
1163
11682
9
73
1185
11820
—
—
—
21
44
1150
11634
42
132
1037
10504
Plastic And Reconstructive Surgery
24 [38004467]
8.3e-01
9.4e-01
—
—
—
9.7e-01
4.6e-01
cases:3.52%
controls:1.56%
cases:1.84%
controls:0.73%
—
—
—
—
—
—
cases:1.37%
controls:0.52%
cases:2.97%
controls:1.90%
42
186
1152
11707
22
87
1172
11806
—
—
—
16
61
1155
11617
32
202
1047
10434
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3.1e-01
3.3e-01
8.6e-01
—
8.6e-01
3.3e-01
3.6e-01
cases:17.09%
controls:13.13%
cases:10.30%
controls:7.63%
cases:2.35%
controls:1.01%
—
—
cases:2.35%
controls:1.00%
cases:11.27%
controls:8.35%
cases:27.43%
controls:20.84%
204
1562
990
10331
123
907
1071
10986
28
120
1166
11773
—
28
119
1166
11758
132
975
1039
10703
296
2217
783
8419
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.08%
—
—
—
—
—
—
12
8
1067
10628
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.08%
—
—
—
—
—
—
12
8
1067
10628
Anterior fusion of cervical spine without fixation
NAG40 [2001307112]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.06%
—
—
—
—
—
—
9
6
1070
10630
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
5.8e-01
6.1e-01
2.2e-01
—
2.0e-01
8.3e-01
6.7e-01
cases:8.88%
controls:5.19%
cases:3.52%
controls:1.94%
cases:0.42%
controls:0.34%
—
—
cases:0.50%
controls:0.41%
cases:4.44%
controls:1.98%
cases:10.47%
controls:5.67%
106
617
1088
11276
42
231
1152
11662
5
40
1189
11853
—
6
49
1188
11828
52
231
1119
11447
113
603
966
10033
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
8.7e-01
1.1e+00
—
—
—
6.8e-01
6.7e-01
cases:7.62%
controls:3.35%
cases:3.18%
controls:1.03%
—
—
—
—
—
—
cases:1.96%
controls:1.00%
cases:6.12%
controls:3.22%
91
399
1103
11494
38
123
1156
11770
—
—
—
23
117
1148
11561
66
342
1013
10294
orphenadrine, combinations
M03BC51 [21604113]
8.7e-01
1.1e+00
—
—
—
6.9e-01
6.7e-01
cases:6.95%
controls:3.04%
cases:2.93%
controls:0.97%
—
—
—
—
—
—
cases:1.88%
controls:0.95%
cases:5.84%
controls:3.07%
83
362
1111
11531
35
115
1159
11778
—
—
—
22
111
1149
11567
63
327
1016
10309
formoterol; inhalant
R03AC13 [21603267]
1.4e+00
1.3e+00
—
—
-1.0e+50
1.1e+00
1.3e+00
cases:1.34%
controls:0.34%
cases:0.67%
controls:0.18%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.60%
controls:0.21%
cases:1.58%
controls:0.44%
16
41
1178
11852
8
22
1186
11871
—
—
0
6
1194
11871
7
24
1164
11654
17
47
1062
10589
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
2.6e+00
—
—
—
—
—
—
cases:0.59%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
1187
11888
—
—
—
—
—
—
Discission of sheath of tendon of wrist or hand
NDM40 [2001307726]
1.8e+00
—
—
—
—
—
2.6e+00
cases:0.50%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.30%
controls:0.09%
6
10
1188
11883
—
—
—
—
—
14
10
1065
10626
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 [3009991]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.05%
—
—
—
—
—
—
7
5
1072
10631
Puncture and needle biopsy of soft tissue, unspecified region
TNX00 [2001308558]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.05%
—
—
—
—
—
—
7
5
1072
10631
cefalexin; oral
J01DB01 [21602870]
6.2e-01
7.3e-01
3.2e-01
—
5.5e-01
7.0e-01
5.7e-01
cases:36.52%
controls:23.67%
cases:14.07%
controls:7.28%
cases:1.17%
controls:0.86%
—
—
cases:1.34%
controls:0.77%
cases:13.58%
controls:7.21%
cases:36.89%
controls:24.93%
436
2815
758
9078
168
866
1026
11027
14
102
1180
11791
—
16
92
1178
11785
159
842
1012
10836
398
2652
681
7984
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
6.6e-01
—
—
—
1.0e+00
1.5e+00
cases:2.51%
controls:0.85%
cases:0.50%
controls:0.26%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:2.32%
controls:0.52%
30
101
1164
11792
6
31
1188
11862
—
—
—
9
33
1162
11645
25
55
1054
10581
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
6.6e-01
—
—
—
1.0e+00
1.5e+00
cases:2.51%
controls:0.85%
cases:0.50%
controls:0.26%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:2.32%
controls:0.52%
30
101
1164
11792
6
31
1188
11862
—
—
—
9
33
1162
11645
25
55
1054
10581
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
6.6e-01
—
—
—
1.0e+00
1.5e+00
cases:2.51%
controls:0.85%
cases:0.50%
controls:0.26%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:2.32%
controls:0.52%
30
101
1164
11792
6
31
1188
11862
—
—
—
9
33
1162
11645
25
55
1054
10581
FEV1 percent change
69983-5 [42868472]
1.1e+00
6.6e-01
—
—
—
1.0e+00
1.5e+00
cases:2.51%
controls:0.85%
cases:0.50%
controls:0.26%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:2.32%
controls:0.52%
30
101
1164
11792
6
31
1188
11862
—
—
—
9
33
1162
11645
25
55
1054
10581
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
6.6e-01
—
—
—
1.0e+00
1.5e+00
cases:2.51%
controls:0.85%
cases:0.50%
controls:0.26%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:2.32%
controls:0.52%
30
101
1164
11792
6
31
1188
11862
—
—
—
9
33
1162
11645
25
55
1054
10581
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.08%
—
—
—
—
—
—
11
8
1068
10628
Otolaryngology
4 [38004449]
6.3e-01
6.0e-01
1.5e-01
—
3.6e-02
5.6e-01
8.0e-01
cases:14.24%
controls:8.14%
cases:4.86%
controls:2.72%
cases:0.42%
controls:0.36%
—
—
cases:0.42%
controls:0.40%
cases:5.04%
controls:2.94%
cases:16.40%
controls:8.10%
170
968
1024
10925
58
323
1136
11570
5
43
1189
11850
—
5
48
1189
11829
59
343
1112
11335
177
861
902
9775
Low back symptom/complaint
L03 [2002000628]
1.0e+00
8.4e-01
—
—
—
7.3e-01
7.5e-01
cases:4.19%
controls:1.58%
cases:2.18%
controls:0.95%
—
—
—
—
—
—
cases:1.88%
controls:0.92%
cases:6.21%
controls:3.04%
50
188
1144
11705
26
113
1168
11780
—
—
—
22
107
1149
11571
67
323
1012
10313
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
3.6e-01
4.2e-01
9.5e-01
—
8.1e-01
4.5e-01
4.1e-01
cases:13.90%
controls:10.08%
cases:8.04%
controls:5.44%
cases:1.76%
controls:0.69%
—
—
cases:1.68%
controls:0.75%
cases:8.80%
controls:5.81%
cases:21.69%
controls:15.53%
166
1199
1028
10694
96
647
1098
11246
21
82
1173
11811
—
20
89
1174
11788
103
679
1068
10999
234
1652
845
8984
Treatment of a patient needing special arrangements
WYA30 [2001310874]
1.0e-01
—
—
—
—
1.6e+00
9.4e-01
cases:0.67%
controls:0.61%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.14%
cases:1.76%
controls:0.70%
8
72
1186
11821
—
—
—
—
8
16
1163
11662
19
74
1060
10562
oxazepam; oral
N05BA04 [21604569]
4.4e-01
5.4e-01
4.6e-01
-1.0e+50
1.1e+00
6.4e-01
7.8e-01
cases:5.28%
controls:3.46%
cases:3.35%
controls:1.98%
cases:0.84%
controls:0.53%
cases:0.00%
controls:0.04%
cases:1.34%
controls:0.44%
cases:3.67%
controls:1.97%
cases:8.71%
controls:4.18%
63
412
1131
11481
40
236
1154
11657
10
63
1184
11830
0
5
1194
11888
16
52
1178
11825
43
230
1128
11448
94
445
985
10191
Disorder of ligament
M24.2 [45557839]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
9
7
1070
10629
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 [40759883]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
9
7
1070
10629
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
9
7
1070
10629
Cervicalgia
M54.2 [45591867]
1.4e+00
1.7e+00
—
—
—
1.2e+00
1.1e+00
cases:1.59%
controls:0.40%
cases:0.59%
controls:0.11%
—
—
—
—
—
—
cases:0.43%
controls:0.13%
cases:1.85%
controls:0.60%
19
47
1175
11846
7
13
1187
11880
—
—
—
5
15
1166
11663
20
64
1059
10572
glucosamine; oral
M01AX05 [21604002]
4.3e-01
8.8e-01
1.4e+00
—
1.1e+00
9.2e-01
7.4e-01
cases:3.60%
controls:2.36%
cases:2.18%
controls:0.92%
cases:0.42%
controls:0.10%
—
—
cases:0.50%
controls:0.16%
cases:2.48%
controls:1.00%
cases:6.58%
controls:3.26%
43
281
1151
11612
26
109
1168
11784
5
12
1189
11881
—
6
19
1188
11858
29
117
1142
11561
71
347
1008
10289
methylprednisolone; oral, parenteral
H02AB04 [21602732]
7.0e-01
1.0e+00
—
—
—
3.9e-01
8.1e-01
cases:3.02%
controls:1.52%
cases:1.59%
controls:0.58%
—
—
—
—
—
—
cases:0.77%
controls:0.52%
cases:3.24%
controls:1.48%
36
181
1158
11712
19
69
1175
11824
—
—
—
9
61
1162
11617
35
157
1044
10479
Cervicocranial syndrome
M53.0 [45562750]
9.4e-01
1.6e+00
—
—
—
1.2e+00
8.9e-01
cases:0.92%
controls:0.36%
cases:0.92%
controls:0.18%
—
—
—
—
—
—
cases:0.68%
controls:0.21%
cases:1.85%
controls:0.77%
11
43
1183
11850
11
22
1183
11871
—
—
—
8
25
1163
11653
20
82
1059
10554
cetirizine; oral
R06AE07 [21603497]
4.0e-01
7.3e-01
4.6e-01
—
1.2e-01
7.5e-01
6.2e-01
cases:10.47%
controls:7.26%
cases:5.78%
controls:2.88%
cases:0.75%
controls:0.48%
—
—
cases:0.50%
controls:0.45%
cases:5.89%
controls:2.88%
cases:11.58%
controls:6.56%
125
864
1069
11029
69
343
1125
11550
9
57
1185
11836
—
6
53
1188
11824
69
336
1102
11342
125
698
954
9938
hydrocortisone
S02BA01 [21605166]
4.3e-01
7.0e-01
—
—
—
7.7e-01
6.0e-01
cases:7.29%
controls:4.89%
cases:2.93%
controls:1.48%
—
—
—
—
—
—
cases:3.07%
controls:1.45%
cases:8.90%
controls:5.08%
87
581
1107
11312
35
176
1159
11717
—
—
—
36
169
1135
11509
96
540
983
10096
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.8e-01
7.2e-01
4.5e-01
—
9.2e-01
6.8e-01
6.1e-01
cases:7.96%
controls:5.10%
cases:5.53%
controls:2.76%
cases:0.92%
controls:0.59%
—
—
cases:1.26%
controls:0.51%
cases:4.95%
controls:2.58%
cases:12.60%
controls:7.28%
95
606
1099
11287
66
328
1128
11565
11
70
1183
11823
—
15
60
1179
11817
58
301
1113
11377
136
774
943
9862
Post-traumatic arthrosis of other joints
M19.1 [45596496]
—
—
—
—
—
2.5e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:0.56%
controls:0.15%
—
—
—
—
—
6
5
1165
11673
6
16
1073
10620
Spirometry
127783003 [4133840]
—
—
—
—
—
2.5e+00
9.4e-01
—
—
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:0.65%
controls:0.25%
—
—
—
—
—
6
5
1165
11673
7
27
1072
10609
bupivacaine
N01BB01 [21604229]
4.8e-01
2.5e+00
—
—
—
—
—
cases:0.42%
controls:0.26%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
5
31
1189
11862
6
5
1188
11888
—
—
—
—
—
electrolytes
B05BB01 [21601161]
4.8e-01
2.5e+00
—
—
—
—
—
cases:0.42%
controls:0.26%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
5
31
1189
11862
6
5
1188
11888
—
—
—
—
—
bupivacaine, combinations
N01BB51 [21604240]
4.8e-01
2.5e+00
—
—
—
—
—
cases:0.42%
controls:0.26%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
5
31
1189
11862
6
5
1188
11888
—
—
—
—
—
amides - combinations
N01BB20 [21604239]
4.8e-01
2.5e+00
—
—
—
—
—
cases:0.42%
controls:0.26%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
5
31
1189
11862
6
5
1188
11888
—
—
—
—
—
Shoulder and humerus MRI examination with high intensity magnet
NB1BG [2001307231]
1.3e+00
2.5e+00
—
1.0e+50
—
—
1.4e+00
cases:0.42%
controls:0.11%
cases:0.50%
controls:0.04%
—
—
cases:0.50%
controls:0.00%
—
—
—
—
cases:0.83%
controls:0.22%
5
13
1189
11880
6
5
1188
11888
—
6
0
1188
11893
—
—
9
23
1070
10613
Intra artrial injection of shoulder with ultrasound guidance
NB2AT [2001307403]
2.5e+00
—
—
—
—
—
1.8e+00
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.08%
6
5
1188
11888
—
—
—
—
—
5
8
1074
10628
electrolytes with carbohydrates
B05BB02 [21601162]
4.4e-01
2.5e+00
—
—
—
—
—
cases:0.42%
controls:0.27%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
5
32
1189
11861
6
5
1188
11888
—
—
—
—
—
Intervertebral disc disorder, unspecified
M51.9 [45596590]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.05%
—
—
—
—
—
—
6
5
1073
10631
Day surgery
ZXD20 [2001311388]
9.0e-01
1.1e+00
—
1.0e+50
-1.0e+50
1.6e+00
6.9e-01
cases:2.18%
controls:0.90%
cases:0.75%
controls:0.26%
—
—
cases:0.50%
controls:0.00%
cases:0.00%
controls:0.05%
cases:1.11%
controls:0.23%
cases:1.85%
controls:0.94%
26
107
1168
11786
9
31
1185
11862
—
6
0
1188
11893
0
6
1194
11871
13
27
1158
11651
20
100
1059
10536
salbutamol; inhalant
R03AC02 [21603256]
5.6e-01
5.5e-01
6.1e-01
—
6.8e-01
6.4e-01
7.0e-01
cases:15.66%
controls:9.55%
cases:7.71%
controls:4.59%
cases:1.51%
controls:0.82%
—
—
cases:1.42%
controls:0.72%
cases:9.14%
controls:5.02%
cases:20.76%
controls:11.47%
187
1136
1007
10757
92
546
1102
11347
18
98
1176
11795
—
17
86
1177
11791
107
586
1064
11092
224
1220
855
9416
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
1.0e+00
6.5e-01
—
—
—
1.4e+00
1.4e+00
cases:1.51%
controls:0.55%
cases:0.42%
controls:0.22%
—
—
—
—
—
—
cases:0.77%
controls:0.19%
cases:2.41%
controls:0.58%
18
65
1176
11828
5
26
1189
11867
—
—
—
9
22
1162
11656
26
62
1053
10574
Upper gastrointestinal surgery
106 [44777669]
4.3e-01
6.1e-01
4.8e-01
—
6.5e-01
7.5e-01
6.6e-01
cases:8.04%
controls:5.36%
cases:3.85%
controls:2.14%
cases:0.50%
controls:0.31%
—
—
cases:0.42%
controls:0.22%
cases:4.01%
controls:1.94%
cases:11.58%
controls:6.35%
96
637
1098
11256
46
254
1148
11639
6
37
1188
11856
—
5
26
1189
11851
47
226
1124
11452
125
675
954
9961
Dry eye syndrome
H04.10 [2000502254]
1.1e+00
1.1e+00
-1.0e+50
—
—
1.4e+00
6.9e-01
cases:1.34%
controls:0.45%
cases:0.84%
controls:0.27%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.02%
controls:0.27%
cases:2.13%
controls:1.08%
16
54
1178
11839
10
32
1184
11861
0
7
1194
11886
—
—
12
31
1159
11647
23
115
1056
10521
hydrocortisone
C05AA01 [21601608]
4.5e-01
6.7e-01
—
—
—
7.4e-01
5.9e-01
cases:8.54%
controls:5.64%
cases:3.43%
controls:1.78%
—
—
—
—
—
—
cases:3.59%
controls:1.75%
cases:10.29%
controls:5.98%
102
671
1092
11222
41
212
1153
11681
—
—
—
42
204
1129
11474
111
636
968
10000
hydrocortisone
A07EA02 [21600654]
4.5e-01
6.7e-01
—
—
—
7.4e-01
5.9e-01
cases:8.54%
controls:5.64%
cases:3.43%
controls:1.78%
—
—
—
—
—
—
cases:3.59%
controls:1.75%
cases:10.29%
controls:5.98%
102
671
1092
11222
41
212
1153
11681
—
—
—
42
204
1129
11474
111
636
968
10000
hydrocortisone
D07AA02 [21602102]
4.7e-01
6.6e-01
—
—
—
7.3e-01
5.8e-01
cases:8.54%
controls:5.52%
cases:3.35%
controls:1.76%
—
—
—
—
—
—
cases:3.50%
controls:1.72%
cases:10.10%
controls:5.90%
102
656
1092
11237
40
209
1154
11684
—
—
—
41
201
1130
11477
109
627
970
10009
hydrocortisone aceponate
D07AC16 [21602135]
4.7e-01
6.6e-01
—
—
—
7.3e-01
5.8e-01
cases:8.54%
controls:5.52%
cases:3.35%
controls:1.76%
—
—
—
—
—
—
cases:3.50%
controls:1.72%
cases:10.10%
controls:5.90%
102
656
1092
11237
40
209
1154
11684
—
—
—
41
201
1130
11477
109
627
970
10009
hydrocortisone butyrate
D07AB02 [21602106]
4.7e-01
6.6e-01
—
—
—
7.3e-01
5.8e-01
cases:8.54%
controls:5.52%
cases:3.35%
controls:1.76%
—
—
—
—
—
—
cases:3.50%
controls:1.72%
cases:10.10%
controls:5.90%
102
656
1092
11237
40
209
1154
11684
—
—
—
41
201
1130
11477
109
627
970
10009
hydrocortisone buteprate
D07AB11 [21602115]
4.7e-01
6.6e-01
—
—
—
7.3e-01
5.8e-01
cases:8.54%
controls:5.52%
cases:3.35%
controls:1.76%
—
—
—
—
—
—
cases:3.50%
controls:1.72%
cases:10.10%
controls:5.90%
102
656
1092
11237
40
209
1154
11684
—
—
—
41
201
1130
11477
109
627
970
10009
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
7.1e-01
8.5e-01
—
—
1.8e+00
9.0e-01
8.2e-01
cases:3.35%
controls:1.67%
cases:1.59%
controls:0.69%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.88%
controls:0.77%
cases:4.73%
controls:2.13%
40
199
1154
11694
19
82
1175
11811
—
—
6
10
1188
11867
22
90
1149
11588
51
227
1028
10409
Squamous intraepithelial neoplasia, high grade of cervix uteri
8077/2-C53.9 [44501336]
—
—
—
—
—
-1.0e+50
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.74%
controls:0.07%
—
—
—
—
—
0
5
1171
11673
8
7
1071
10629
Polyneuropathy, unspecified
G62.9 [45566898]
1.1e+00
1.8e+00
—
—
—
2.4e+00
1.0e+00
cases:0.59%
controls:0.19%
cases:0.42%
controls:0.07%
—
—
—
—
—
—
cases:0.77%
controls:0.07%
cases:0.56%
controls:0.20%
7
23
1187
11870
5
8
1189
11885
—
—
—
9
8
1162
11670
6
21
1073
10615
Shoulder ultrasound examination
NB1AE [2001307227]
2.4e+00
—
—
—
—
—
—
cases:0.75%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
9
8
1185
11885
—
—
—
—
—
—
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.08%
—
—
—
—
—
—
9
8
1070
10628
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
6.2e-01
1.3e+00
—
—
—
5.4e-01
5.0e-01
cases:7.96%
controls:4.43%
cases:4.69%
controls:1.35%
—
—
—
—
—
—
cases:2.31%
controls:1.36%
cases:7.04%
controls:4.41%
95
527
1099
11366
56
161
1138
11732
—
—
—
27
159
1144
11519
76
469
1003
10167
diclofenac, combinations; oral
M01AB55 [21603959]
1.1e+00
—
—
—
—
1.8e+00
1.3e+00
cases:1.34%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:1.11%
controls:0.32%
16
54
1178
11839
—
—
—
—
5
8
1166
11670
12
34
1067
10602
triamcinolone; nasal
R01AD11 [21605052]
1.1e+00
1.2e+00
—
—
—
6.9e-01
1.3e+00
cases:2.26%
controls:0.78%
cases:0.75%
controls:0.24%
—
—
—
—
—
—
cases:0.51%
controls:0.26%
cases:1.85%
controls:0.54%
27
93
1167
11800
9
28
1185
11865
—
—
—
6
30
1165
11648
20
57
1059
10579
misoprostol; oral, vaginal
G02AD06 [21602443]
1.1e+00
—
—
—
—
1.8e+00
1.3e+00
cases:1.34%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:1.11%
controls:0.32%
16
55
1178
11838
—
—
—
—
5
8
1166
11670
12
34
1067
10602
misoprostol; oral
A02BB01 [21600093]
1.1e+00
—
—
—
—
1.8e+00
1.3e+00
cases:1.34%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:1.11%
controls:0.32%
16
55
1178
11838
—
—
—
—
5
8
1166
11670
12
34
1067
10602
potassium chloride; oral
A12BA01 [21600877]
3.6e-01
2.2e-01
—
—
—
1.2e+00
1.1e+00
cases:1.09%
controls:0.77%
cases:0.67%
controls:0.54%
—
—
—
—
—
—
cases:1.71%
controls:0.50%
cases:2.78%
controls:0.97%
13
91
1181
11802
8
64
1186
11829
—
—
—
20
58
1151
11620
30
103
1049
10533
Pain, unspecified
R52.9 [45544151]
9.4e-01
2.3e+00
—
—
—
1.1e+00
8.0e-01
cases:1.34%
controls:0.53%
cases:1.09%
controls:0.11%
—
—
—
—
—
—
cases:0.77%
controls:0.25%
cases:1.76%
controls:0.80%
16
63
1178
11830
13
13
1181
11880
—
—
—
9
29
1162
11649
19
85
1060
10551
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
5.1e-01
—
—
—
—
2.3e+00
8.4e-01
cases:0.67%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.06%
cases:1.02%
controls:0.44%
8
48
1186
11845
—
—
—
—
7
7
1164
11671
11
47
1068
10589
Shoulder and humerus extensive MRI examination with high intensity magnet
NB1CG [2001307237]
2.3e+00
—
—
1.0e+50
—
1.0e+50
1.9e+00
cases:0.67%
controls:0.07%
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.60%
controls:0.00%
cases:0.56%
controls:0.08%
8
8
1186
11885
—
—
6
0
1188
11893
—
7
0
1164
11678
6
9
1073
10627
Fracture of upper end of humerus
S42.2 [45544677]
-1.0e+50
1.5e+00
—
—
—
2.3e+00
7.9e-01
cases:0.00%
controls:0.16%
cases:0.42%
controls:0.09%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.74%
controls:0.34%
0
19
1194
11874
5
11
1189
11882
—
—
—
6
6
1165
11672
8
36
1071
10600
Hip X-ray examination
NF1AA [2001307894]
1.2e+00
—
—
—
—
—
1.1e+00
cases:1.17%
controls:0.34%
—
—
—
—
—
—
—
—
—
—
cases:1.58%
controls:0.55%
14
41
1180
11852
—
—
—
—
—
17
58
1062
10578
methylprednisolone, combinations
H02BX01 [21602747]
6.0e-01
2.3e+00
—
—
—
—
—
cases:0.50%
controls:0.28%
cases:0.50%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
6
33
1188
11860
6
6
1188
11887
—
—
—
—
—
Forcible manipulation of humeroscapular joint
NBT60 [2001307399]
2.3e+00
—
—
—
—
—
—
cases:0.50%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
1188
11887
—
—
—
—
—
—
Synovitis and tenosynovitis, unspecified
M65.9 [45567618]
1.3e+00
2.3e+00
—
—
—
—
6.4e-01
cases:0.42%
controls:0.11%
cases:0.50%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.24%
5
13
1189
11880
6
6
1188
11887
—
—
—
—
5
26
1074
10610
Dorsalgia, unspecified
M54.9 [45538791]
1.1e+00
1.2e+00
—
—
—
8.9e-01
3.2e-01
cases:2.01%
controls:0.68%
cases:1.01%
controls:0.30%
—
—
—
—
—
—
cases:0.77%
controls:0.32%
cases:1.39%
controls:1.02%
24
81
1170
11812
12
36
1182
11857
—
—
—
9
37
1162
11641
15
108
1064
10528
Sodium [Moles/volume] in Urine
2955-3 [3003181]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.09%
—
—
—
—
—
—
10
10
1069
10626
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
7.3e-01
1.5e+00
—
—
—
—
2.3e+00
cases:0.42%
controls:0.20%
cases:0.42%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.08%
5
24
1189
11869
5
11
1189
11882
—
—
—
—
8
8
1071
10628
Shoulder syndrome
L92 [2002000711]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.07%
—
—
—
—
—
—
7
7
1072
10629
Atypical facial pain
G50.1 [45542894]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.07%
—
—
—
—
—
—
7
7
1072
10629
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
D21.1 [45537899]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.06%
—
—
—
—
—
—
6
6
1073
10630
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
5.8e-01
9.1e-01
—
—
—
6.6e-01
8.0e-01
cases:4.86%
controls:2.77%
cases:2.76%
controls:1.14%
—
—
—
—
—
—
cases:2.22%
controls:1.16%
cases:8.62%
controls:4.08%
58
330
1136
11563
33
135
1161
11758
—
—
—
26
135
1145
11543
93
434
986
10202
Acute maxillary sinusitis
J01.0 [45601112]
7.9e-01
8.6e-01
—
—
—
4.3e-01
6.1e-01
cases:4.52%
controls:2.11%
cases:1.93%
controls:0.82%
—
—
—
—
—
—
cases:1.28%
controls:0.84%
cases:5.38%
controls:2.98%
54
251
1140
11642
23
98
1171
11795
—
—
—
15
98
1156
11580
58
317
1021
10319
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.6e-01
7.1e-01
5.8e-01
—
4.0e-01
5.0e-01
6.8e-01
cases:12.40%
controls:8.96%
cases:8.38%
controls:4.31%
cases:1.01%
controls:0.56%
—
—
cases:0.75%
controls:0.51%
cases:7.51%
controls:4.70%
cases:22.15%
controls:12.61%
148
1066
1046
10827
100
513
1094
11380
12
67
1182
11826
—
9
60
1185
11817
88
549
1083
11129
239
1341
840
9295
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
4.6e-01
5.8e-01
—
—
-1.0e+50
1.2e+00
1.0e+00
cases:1.59%
controls:1.01%
cases:0.59%
controls:0.33%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.28%
controls:0.39%
cases:3.43%
controls:1.25%
19
120
1175
11773
7
39
1187
11854
—
—
0
6
1194
11871
15
45
1156
11633
37
133
1042
10503
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
-1.6e-02
7.6e-01
-1.0e+50
—
—
1.2e+00
1.1e+00
cases:0.67%
controls:0.68%
cases:0.84%
controls:0.40%
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.20%
controls:0.38%
cases:2.59%
controls:0.90%
8
81
1186
11812
10
47
1184
11846
0
11
1194
11882
—
—
14
44
1157
11634
28
96
1051
10540
Bacteria identified in Blood by Culture
600-7 [3023368]
3.0e-01
7.9e-01
—
—
—
8.5e-01
5.9e-01
cases:3.02%
controls:2.26%
cases:1.93%
controls:0.88%
—
—
—
—
—
—
cases:1.88%
controls:0.81%
cases:5.10%
controls:2.89%
36
269
1158
11624
23
105
1171
11788
—
—
—
22
95
1149
11583
55
307
1024
10329

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
492
3146
1.94
26.64
2.6
2.1
237.59
221.08
u/l
0.15
478
2984
387
2364
1.93
23.40
4.7
3.6
1.02
1.02
kg/l
0.80
262
1552
497
3347
1.81
21.71
2.9
2.5
209.17
62.49
u/l
0.46
477
3106
974
8186
1.90
18.54
4.8
4.3
14.76
14.68
pmol/l
0.48
921
7575
719
5577
1.69
17.67
6.7
6.9
10.86
11.82
umol/l
1.05
692
5349
317
1981
1.81
16.97
1.5
1.3
24.93
32.42
iu/ml
0.52
99
601
821
6660
1.70
16.46
5.4
4.3
31.50
1382.60
e6/l
2.04
12
99
607
4559
1.65
16.41
5.2
5.3
36.08
36.04
g/l
0.06
575
4303
292
1814
1.80
15.80
1.4
1.3
4.89
14.14
u/ml
2.66
95
719
505
3669
1.64
15.23
3.6
3.3
38.39
33.42
u/l
0.37
478
3482
761
6132
1.63
14.89
6.0
5.3
6.80
6.62
mmol/l
1.24
728
5812
205
1179
1.89
14.08
1.7
1.6
—
—
—
0
0
601
4650
1.57
13.36
12.6
13.6
1.17
1.22
inr
2.08
506
3849
946
8148
1.69
13.33
9.3
8.2
76.45
78.78
u/l
1.15
919
7772
352
2398
1.65
13.33
1.8
1.7
1.35
1.12
mg/l
0.27
272
1828
697
5583
1.57
13.26
4.4
3.6
0.00
7.10
estimate
1.59
134
1152
622
4861
1.56
13.15
2.9
2.7
—
—
estimate
—
0
0
1086
9752
1.95
13.06
6.0
5.2
1.76
1.88
mu/l
3.22
1034
9097
235
1450
1.77
12.75
2.1
2.0
—
—
—
0
0
691
5556
1.55
12.68
6.8
6.5
2.09
1.89
e9/l
0.53
636
4908
698
5626
1.55
12.66
4.5
3.6
0.08
0.29
estimate
0.33
132
1084
644
5107
1.55
12.51
8.2
7.5
1.21
1.21
mmol/l
0.48
569
4417
678
5438
1.55
12.51
6.7
6.4
0.56
0.58
e9/l
0.65
612
4677
440
3221
1.57
12.15
6.4
6.3
—
—
—
0
0
26
54
4.90
11.93
1.3
1.1
0.48
0.52
ratio
0.74
12
28
837
7073
1.57
11.93
4.9
4.3
—
3.21
—
0
10
511
3882
1.54
11.88
4.4
3.4
60.82
64.83
ng/l
0.04
338
2633
684
5534
1.53
11.86
4.5
3.6
0.00
0.00
estimate
0.50
138
1142
744
6130
1.54
11.85
10.4
10.2
4.21
4.06
e9/l
0.63
684
5334
675
5448
1.53
11.82
6.8
6.4
0.04
0.04
e9/l
0.42
607
4686
235
1486
1.72
11.60
1.4
1.3
564.76
525.64
titre
0.10
42
312
690
5615
1.52
11.48
7.0
6.7
0.20
0.19
e9/l
1.33
633
4907
188
1140
1.77
10.71
7.8
10.4
7.41
7.41
ph
0.01
122
612
364
2615
1.56
10.64
2.4
2.2
2.74
2.80
mg/l
0.24
320
2272
412
3042
1.53
10.63
4.5
4.3
7.40
7.40
ph
0.17
313
2165
1132
10449
2.01
10.50
21.0
14.5
22.28
24.08
mg/l
1.11
968
8508
405
2989
1.53
10.43
4.6
3.8
0.00
0.01
estimate
1.15
131
1071
572
4534
1.49
10.43
2.2
2.0
92.65
95.88
pmol/l
0.98
291
2444
185
1132
1.75
10.19
7.6
10.3
1.66
0.84
mmol/l
2.74
152
945
538
4228
1.48
10.15
4.4
3.5
0.03
0.03
estimate
0.02
113
940
74
328
2.34
10.12
8.5
9.2
—
—
—
0
0
1153
10734
2.13
10.11
22.8
17.1
3.98
3.96
mmol/l
1.43
1136
10511
574
4573
1.48
10.09
7.6
6.9
1.21
1.21
mmol/l
0.25
543
4232
48
174
2.83
9.90
3.2
2.3
—
—
—
0
0
1150
10715
2.08
9.75
22.8
16.9
139.49
139.73
mmol/l
2.49
1136
10512
28
73
3.90
9.71
1.1
1.1
32.72
42.69
mg/l
0.86
23
62
282
1949
1.58
9.64
4.4
3.7
270.30
507.53
ng/l
0.86
221
1474
385
2855
1.51
9.53
3.4
2.9
—
—
—
0
0
109
589
1.93
8.95
7.9
8.6
24.50
24.42
mmol/l
0.08
104
566
77
366
2.18
8.94
2.1
2.1
1464.86
396.83
ug/l
0.52
72
351
237
1600
1.60
8.88
2.1
2.1
29.77
29.62
s
0.11
232
1552
180
1141
1.68
8.66
7.8
10.3
12.96
12.32
kpa
0.79
172
1106
180
1141
1.68
8.66
7.8
10.3
5.08
5.12
kpa
0.22
172
1104
166
1030
1.71
8.65
7.8
10.9
95.97
95.47
%
0.44
161
998
552
4455
1.43
8.60
4.2
3.2
6.29
6.19
ph
1.35
320
2549
367
2743
1.48
8.58
4.6
4.3
—
—
—
0
0
84
423
2.06
8.41
4.7
7.6
1.67
1.59
%
0.34
79
401
462
3621
1.44
8.39
3.1
3.7
2.34
2.36
mmol/l
1.35
423
3320
615
5083
1.42
8.28
3.4
3.0
130.07
128.82
ug/l
0.03
581
4779
77
378
2.11
8.25
4.9
8.2
0.78
0.86
%
1.04
72
355
611
5047
1.42
8.23
6.9
6.4
56.32
57.19
%
1.08
596
4824
154
953
1.70
8.09
8.7
11.3
120.86
122.06
g/l
0.28
148
934
290
2088
1.51
8.07
1.9
1.7
422.67
31175893.17
pmol/l
1.94
254
1761
434
3401
1.43
7.74
4.1
3.3
25.14
71.94
e6/l
2.91
345
2580
583
4811
1.40
7.72
2.7
2.4
77.04
76.35
nmol/l
0.23
541
4401
374
2854
1.45
7.70
1.8
1.7
20.99
20.33
nmol/l
0.40
332
2431
251
1778
1.52
7.50
4.2
3.7
0.81
0.82
mmol/l
0.61
239
1696
601
5006
1.39
7.43
7.2
6.6
8.68
8.86
%
0.82
577
4700
455
3617
1.41
7.40
3.6
3.4
7.47
7.89
mmol/l
1.20
402
3093
613
5125
1.39
7.40
7.2
6.6
28.21
27.86
%
0.35
595
4873
117
689
1.77
7.32
2.5
2.4
26.34
17.39
au/ml
0.45
13
87
53
238
2.28
7.10
1.7
1.5
4962.50
16553.13
e6/l
2.65
44
168
162
1054
1.62
7.00
3.9
3.6
7.38
7.38
ph
0.22
89
574
1175
11193
2.04
6.84
14.3
11.6
27.08
26.94
u/l
0.09
1155
10919
222
1565
1.51
6.73
2.9
2.6
2.32
2.33
g/l
0.10
206
1460
56
264
2.17
6.69
1.6
1.3
562.32
503.69
mg/l
0.32
56
249
236
1688
1.49
6.67
2.9
2.6
12.93
13.62
umol/l
0.71
216
1582
442
3545
1.38
6.66
6.9
6.3
—
—
—
0
0
425
3390
1.39
6.61
2.6
2.3
—
—
—
0
0
127
788
1.68
6.60
3.5
2.8
67.49
66.90
g/l
0.43
120
741
51
233
2.24
6.58
1.6
1.3
20.65
10.85
e6/l
0.30
40
161
594
5001
1.36
6.58
7.3
6.6
0.70
0.69
%
0.24
571
4682
1074
10000
1.57
6.57
7.0
5.9
39.69
38.80
mmol/mol
2.48
1026
9440
1179
11260
2.06
6.57
25.1
18.6
76.69
76.49
umol/l
0.07
1171
11139
82
448
1.89
6.55
2.2
2.2
—
—
—
0
0
306
2309
1.43
6.54
3.2
2.7
6.26
5.69
e6/l
0.28
284
2117
594
5005
1.36
6.53
7.1
6.5
3.05
2.81
%
1.86
570
4698
353
2736
1.41
6.48
2.9
2.7
331.91
342.64
umol/l
1.23
329
2454
51
235
2.22
6.45
1.6
1.4
52.47
947.28
e6/l
0.87
43
173
1091
10208
1.59
6.38
5.3
4.8
5.99
5.89
mmol/l
1.58
1036
9457
71
373
1.96
6.37
1.2
1.2
—
—
—
0
0
72
381
1.94
6.33
1.2
1.1
—
—
—
0
0
204
1432
1.51
6.29
2.9
2.7
21.33
23.58
%
1.49
188
1349
370
2904
1.39
6.28
2.8
3.2
1021.73
1137.21
ng/l
0.33
320
2479
78
426
1.89
6.25
4.1
3.5
25.46
25.27
mmol/l
0.20
73
410
105
635
1.71
6.01
3.3
3.1
133.12
130.44
g/l
0.53
100
622
42
185
2.32
5.93
5.0
13.3
103.73
105.47
mmol/l
0.81
37
167
42
185
2.32
5.93
5.0
13.3
12.49
11.45
mmol/l
0.61
37
167
152
1015
1.57
5.88
2.7
2.4
14.15
13.57
nmol/l
0.36
139
944
205
1468
1.48
5.71
1.2
1.2
—
—
—
0
0
474
3917
1.34
5.68
4.7
3.9
64.32
88.62
e6/l
0.49
357
2739
317
2465
1.38
5.59
1.5
1.3
1.59
1.64
u/ml
0.02
107
675
59
307
1.97
5.48
1.5
1.5
283.26
270.23
ug/g
0.15
27
174
45
213
2.15
5.38
1.4
1.3
—
—
—
0
0
131
864
1.58
5.35
2.7
2.4
0.50
0.51
e6/l
0.00
117
825
141
947
1.55
5.32
7.2
9.2
1.34
1.37
mmol/l
0.12
136
931
418
3425
1.33
5.20
4.3
4.1
7.34
8.37
mg/mmol
0.21
272
2139
410
3360
1.33
5.07
3.5
3.4
45.43
49.63
mg/l
0.15
273
2162
76
443
1.76
4.98
3.0
1.8
—
—
—
0
0
147
1012
1.51
4.96
3.9
3.6
2.10
1.81
mmol/l
0.38
134
873
76
444
1.76
4.95
2.9
1.8
—
—
—
0
0
71
407
1.79
4.93
3.0
1.8
—
—
—
0
0
76
446
1.75
4.87
3.0
1.8
—
—
—
0
0
361
2918
1.34
4.87
4.1
3.2
0.23
0.43
e6/l
2.20
285
2104
75
440
1.75
4.82
3.0
1.8
—
—
—
0
0
835
7572
1.32
4.80
4.0
3.3
51.90
47.80
u/l
0.58
807
7170
89
550
1.67
4.74
1.4
1.2
—
—
—
0
0
37
172
2.19
4.66
2.0
1.3
73.37
62.17
mmol/l
0.55
30
147
100
642
1.61
4.59
3.0
2.6
—
—
—
0
0
73
434
1.72
4.49
1.4
1.2
0.18
1.22
u/ml
—
10
26
69
408
1.73
4.34
2.2
2.1
5.59
2.23
ug/l
0.74
59
374
275
2168
1.35
4.33
1.9
1.5
2.32
2.48
g/l
0.76
177
1373
50
268
1.90
4.32
5.0
10.5
1.59
1.35
mmol/l
0.31
42
233
168
1224
1.43
4.25
3.1
2.9
6.92
8.50
umol/l
0.58
145
1103
181
1340
1.41
4.19
3.6
3.5
5.11
4.83
e9/l
0.09
162
1182
156
1125
1.44
4.18
2.7
2.8
1.83
1.82
%
0.02
140
1031
233
1806
1.36
4.09
3.8
2.8
1.28
1.09
e6/l
0.21
142
929
29
130
2.26
4.01
1.1
1.6
22.05
26.26
ng/l
0.21
29
130
106
715
1.53
3.96
3.8
2.9
156.68
197.21
ng/l
0.52
100
656
141
1009
1.45
3.94
2.0
2.2
376.01
379.09
nmol/l
0.08
131
952
369
3073
1.29
3.87
3.5
3.1
0.01
0.05
estimate
0.64
105
899
205
1574
1.36
3.81
1.9
1.7
1118.90
1216.29
nmol/l
0.91
161
1203
135
966
1.45
3.78
2.2
2.1
0.00
0.02
estimate
0.78
36
212
246
1945
1.33
3.77
3.3
2.9
556.75
533.90
mosm/kgh2o
0.58
224
1714
181
1365
1.38
3.76
2.7
2.6
122.03
122.80
ug/g
0.01
153
1095
100
678
1.52
3.66
2.8
3.8
4.45
4.58
pmol/l
0.73
94
615
175
1319
1.38
3.65
1.4
1.5
—
—
—
0
0
108
745
1.49
3.64
3.8
4.1
80.24
86.10
ng/l
0.37
99
653
114
797
1.47
3.60
2.7
2.3
12.00
7.81
ug/l
0.40
102
720
954
8936
1.30
3.59
23.9
18.2
13.64
13.56
%
1.21
946
8824
131
942
1.44
3.58
7.8
8.3
9.00
9.01
mmol/l
0.00
126
905
34
171
2.02
3.56
1.4
1.3
—
—
—
0
0
27
124
2.20
3.56
1.3
1.2
—
—
—
0
0
85
561
1.55
3.52
7.5
14.9
16.30
16.01
%
0.35
80
544
31
152
2.07
3.48
1.1
1.6
—
—
—
0
0
31
152
2.07
3.48
1.1
1.6
—
—
—
0
0
31
152
2.07
3.48
1.1
1.6
—
—
—
0
0
31
152
2.07
3.48
1.1
1.6
—
—
—
0
0
72
459
1.60
3.46
3.7
3.2
1.02
1.02
ratio
0.40
66
420
127
917
1.43
3.40
8.8
10.3
—
—
—
0
0
10
23
4.37
3.31
1.1
1.2
—
—
—
0
0
25
116
2.18
3.24
1.6
1.2
—
—
—
0
0
305
2530
1.27
3.23
5.6
4.9
—
—
—
0
0
13
39
3.36
3.23
2.2
1.5
—
—
—
0
0
330
2766
1.26
3.20
4.6
3.9
90.49
91.29
%
0.25
321
2709
69
445
1.58
3.18
2.5
1.8
—
—
—
0
0
251
2035
1.29
3.18
2.4
3.1
2.43
2.45
mmol/l
1.45
225
1846
526
4651
1.23
3.13
2.0
1.9
1.40
1.39
mmol/l
0.12
458
3983
21
92
2.30
3.11
1.2
1.2
38412.50
149266.17
e6/l
0.81
16
65
1117
10757
1.40
3.08
6.3
5.6
2.71
2.77
mmol/l
1.44
1071
10099
53
324
1.66
3.03
3.3
3.9
35.30
38.23
mg/l
0.14
45
272
53
324
1.66
3.03
3.2
3.9
34.39
64.75
mg/l
0.92
45
270
1187
11584
1.65
2.90
30.3
22.3
250.98
251.61
e9/l
0.13
1176
11369
68
448
1.55
2.88
1.8
1.8
8.39
7.12
iu/ml
0.10
17
109
16
64
2.52
2.88
1.9
2.9
8.08
8.34
mmol/l
0.11
16
64
1187
11587
1.64
2.86
30.1
22.2
91.11
91.02
fl
0.30
1179
11478
538
4803
1.21
2.82
13.4
11.1
0.00
0.00
e9/l
0.15
451
3927
1187
11590
1.63
2.82
30.2
22.2
4.49
4.53
e12/l
2.37
1172
11346
1187
11590
1.63
2.82
30.1
22.1
30.40
30.36
pg
0.38
1179
11480
1187
11590
1.63
2.82
30.6
22.8
40.56
40.78
%
0.84
1179
11474
1187
11591
1.63
2.80
30.3
22.3
6.85
6.64
e9/l
0.99
1172
11339
115
846
1.40
2.80
3.9
3.0
10.52
10.68
g/l
0.17
107
785
1187
11595
1.62
2.74
30.4
22.4
135.77
136.68
g/l
1.33
1180
11482
31
167
1.88
2.73
1.5
1.5
—
—
—
0
0
45
273
1.67
2.68
2.6
3.2
2.26
2.23
index
0.01
31
152
115
860
1.37
2.56
2.6
2.9
72.50
72.24
e9/l
0.03
89
623
12
44
2.74
2.55
3.0
1.5
—
—
—
0
0
355
3067
1.22
2.55
3.2
2.8
0.00
0.00
—
10
52
156
1224
1.31
2.52
1.3
1.4
—
—
—
0
0
11
37
2.99
2.49
1.5
1.6
69.36
823.95
nmol/24h
0.50
11
37
56
367
1.55
2.47
2.7
2.5
—
—
—
0
0
8
21
3.83
2.46
2.5
3.7
5.88
6.14
ug/l
—
8
21
12
45
2.68
2.45
2.8
4.6
113.00
158.70
umol/l
—
6
23
1100
10631
1.32
2.40
5.6
5.0
4.62
4.69
mmol/l
1.53
1058
10021
1053
10121
1.28
2.39
4.6
4.2
1.30
1.30
mmol/l
0.04
1007
9422
50
323
1.57
2.36
1.5
2.4
9.62
10.58
g/l
1.35
45
299
401
3532
1.20
2.33
3.7
3.3
—
0.69
—
0
13
392
3446
1.20
2.32
5.3
4.9
1.56
2.19
ug/l
3.72
362
3159
46
296
1.58
2.22
1.3
1.2
—
—
—
0
0
1094
10586
1.29
2.20
5.4
4.9
1.45
1.45
mmol/l
0.26
1048
9926
19
95
2.02
2.11
1.9
1.5
48.57
59.10
%
0.44
14
68
18
89
2.04
2.06
1.8
1.7
—
—
—
0
0
201
1674
1.24
2.03
3.9
3.0
2.38
2.42
e6/l
0.02
110
792
91
683
1.36
2.02
11.0
11.8
1.50
1.30
%
1.45
91
678
38
241
1.60
1.97
1.9
2.2
125.97
129.65
g/l
0.41
32
193
106
818
1.32
1.97
2.9
2.2
5.98
6.09
ph
0.80
82
533
26
149
1.76
1.95
3.7
4.4
1.17
1.63
%
0.41
20
138
12
51
2.37
1.95
1.4
1.4
133.50
178.95
mmol/24h
1.37
12
51
92
697
1.35
1.93
3.0
3.2
5.15
5.12
kpa
0.12
86
672
414
4594
0.85
1.93
3.6
3.0
—
—
—
0
0
24
136
1.78
1.88
1.3
1.4
187.84
368.26
pmol/l
3.63
19
120
34
214
1.61
1.84
4.0
4.2
—
—
—
0
0
34
215
1.60
1.81
5.5
3.3
20.84
25.95
mg/l
0.60
25
145
56
397
1.43
1.76
1.9
1.6
242.19
305.28
mu/l
1.16
49
372
21
117
1.81
1.75
1.4
1.2
—
97.38
—
0
6
120
959
1.28
1.74
5.2
4.8
0.87
0.96
%
0.19
36
302
13
61
2.14
1.72
2.0
3.1
16.17
16.52
%
0.16
13
61
116
926
1.28
1.70
5.1
5.2
0.43
0.12
%
0.45
28
234
17
89
1.92
1.70
1.1
1.1
91.76
110.02
pmol/l
0.92
17
89
67
495
1.37
1.68
1.6
1.8
0.34
0.35
mg/l
0.04
30
256
43
293
1.48
1.67
3.2
3.6
1.27
3.36
ratio
0.91
25
156
15
76
1.99
1.64
2.8
3.4
61.84
20.02
mg/l
—
10
55
88
681
1.31
1.64
3.1
3.2
7.42
7.42
ph
0.52
71
578
18
98
1.85
1.62
2.7
3.5
19.54
11.84
index
0.58
13
68
19
107
1.79
1.55
2.2
2.3
3.59
5.61
umol/l
1.14
12
80
38
257
1.49
1.54
1.3
1.2
—
—
—
0
0
14
71
1.98
1.54
1.1
1.1
—
62.24
—
0
5
113
912
1.26
1.54
5.4
4.8
0.07
0.11
%
0.44
30
254
155
1296
1.22
1.54
1.5
1.6
—
—
—
0
0
66
495
1.35
1.53
1.8
2.2
0.00
0.01
estimate
0.50
29
166
123
1008
1.24
1.48
2.4
2.4
0.22
0.21
g/l
0.15
118
948
82
639
1.30
1.47
1.0
1.1
—
—
—
0
0
34
228
1.51
1.45
3.0
3.4
33.55
34.88
umol/l
0.16
29
212
115
1397
0.81
1.43
2.0
2.0
3.57
3.52
ratio
0.13
82
1112
198
1709
1.19
1.42
1.6
1.6
—
—
—
0
0
16
88
1.83
1.42
1.9
2.3
941.50
1223.98
mg
0.31
16
88
31
206
1.52
1.38
1.4
1.2
18.03
31.89
u/l
1.01
25
171
30
198
1.53
1.38
2.3
1.7
—
—
—
0
0
13
68
1.92
1.33
2.8
3.8
0.77
0.96
index
0.68
13
68
111
911
1.24
1.33
4.1
4.7
0.55
0.68
%
0.43
31
283
11
54
2.05
1.33
1.0
1.3
130.91
143.71
nmol/l
0.48
11
54
83
1036
0.79
1.32
1.8
1.8
3.39
3.48
mmol/l
0.30
52
753
100
812
1.25
1.32
1.4
1.2
—
—
—
0
0
229
2021
1.16
1.26
1.8
1.9
—
—
—
0
0
9
45
2.01
1.23
1.8
1.7
3.56
5.72
u/field
—
9
36
127
1071
1.21
1.19
3.7
4.8
7.33
22.16
ug/l
1.09
111
874
6
26
2.31
1.18
1.3
1.4
10.22
8.29
mmol/l
—
6
26
8
38
2.11
1.18
1.9
3.1
0.59
0.61
mmol/l
—
8
38
42
308
1.38
1.17
1.6
2.0
3.64
22.03
iu/l
0.53
16
133
60
465
1.31
1.17
1.2
1.2
—
—
—
0
0
12
65
1.85
1.13
1.7
1.4
4.53
6.16
ug/l
0.96
12
56
87
712
1.24
1.10
1.3
1.3
—
—
—
0
0
16
96
1.68
1.10
1.9
2.2
—
—
—
0
0
83
676
1.24
1.10
3.0
1.8
1.83
1.31
g/l
0.55
78
626
11
194
0.56
1.09
1.4
1.5
—
—
—
0
0
45
341
1.33
1.04
2.2
3.8
211.84
398.36
mg/l
0.61
19
166
7
34
2.06
1.03
1.4
1.5
—
—
—
0
0
12
201
0.59
1.00
1.3
1.6
—
—
—
0
0
27
189
1.44
0.99
1.0
1.1
8.68
16.82
au/ml
—
5
57
20
132
1.52
0.97
1.6
2.2
32.90
32.34
pg
0.20
20
132
125
1077
1.18
0.96
2.7
2.5
31.97
41.99
u/l
1.01
109
922
14
85
1.65
0.94
1.4
1.7
—
—
—
0
0
23
159
1.46
0.91
1.0
1.0
1.83
2.06
eliau/ml
—
6
74
25
176
1.43
0.91
6.8
6.2
349.52
354.98
umol/l
0.08
25
154
41
314
1.32
0.91
1.5
1.4
8.35
9.26
u/l
0.16
33
268
233
2113
1.13
0.89
2.8
3.0
0.62
0.72
ug/l
1.46
150
1284
18
119
1.52
0.88
1.3
1.2
—
—
—
0
0
59
477
1.25
0.87
3.4
3.2
—
—
—
0
0
8
43
1.87
0.87
1.8
2.8
63.13
48.77
umol/l
—
8
38
6
30
2.00
0.87
4.0
3.4
—
—
—
0
0
11
64
1.73
0.86
2.0
1.8
94.21
109.67
ng/l
0.24
11
64
29
214
1.36
0.83
3.7
4.2
—
—
—
0
0
32
240
1.34
0.83
2.1
1.7
—
—
—
0
0
12
73
1.65
0.81
1.3
1.1
—
—
—
0
0
17
114
1.50
0.79
1.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
3.22
—
0
17
13
82
1.59
0.78
1.8
1.8
2173.77
1951.82
ml
0.36
13
82
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
7
39
1.80
0.72
3.0
1.3
—
5.78
%
—
0
9
14
92
1.53
0.72
1.4
1.5
217.01
165.17
pmol/l
0.35
14
92
14
206
0.68
0.71
1.1
1.1
0.03
1.80
u/ml
—
6
89
30
229
1.32
0.71
3.0
3.9
—
—
—
0
0
19
134
1.42
0.71
1.7
1.9
0.72
0.89
%
1.04
13
93
21
151
1.40
0.71
1.4
1.4
0.58
0.66
nmol/l
0.50
21
142
7
40
1.75
0.71
1.6
1.7
33.57
28.05
%
—
7
40
5
26
1.93
0.70
1.4
1.1
17.26
15.84
umol/l
—
5
20
89
1025
0.86
0.70
1.7
1.8
—
—
—
0
0
9
143
0.63
0.70
1.1
1.2
—
—
—
0
0
88
761
1.17
0.69
1.2
1.2
144.49
142.97
u/ml
0.01
44
303
135
1205
1.14
0.69
1.4
1.4
—
—
—
0
0
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
45
367
1.23
0.66
1.4
1.3
237.05
227.66
miu/ml
0.06
20
170
12
78
1.54
0.65
1.3
1.1
—
—
—
0
0
8
128
0.62
0.64
3.0
2.3
—
—
—
0
0
5
29
1.73
0.64
12.8
6.3
11.80
8.59
%
—
5
29
5
29
1.73
0.64
6.4
3.1
38.00
48.55
%
—
5
29
8
50
1.60
0.61
1.3
1.7
—
—
—
0
0
65
557
1.18
0.59
2.4
3.5
20.74
80.97
u/ml
2.00
65
538
42
345
1.23
0.59
2.4
2.3
10337.95
4233.23
u/l
0.43
19
144
14
97
1.45
0.59
2.0
4.3
47.25
54.95
%
—
8
90
6
35
1.72
0.57
4.0
3.1
—
—
—
0
0
8
55
1.46
0.56
3.9
1.3
25.94
28.92
umol/l
—
8
48
6
39
1.54
0.53
2.5
1.8
40.88
41.44
g/l
—
6
39
13
91
1.43
0.53
1.2
1.2
—
—
—
0
0
16
215
0.74
0.52
1.1
1.1
0.37
5.23
u/ml
—
8
119
105
943
1.12
0.52
5.0
3.9
7.36
7.35
ph
0.05
82
684
331
3140
1.07
0.51
1.4
1.5
—
—
—
0
0
66
575
1.16
0.51
1.3
1.4
31.03
27.58
iu/l
0.32
55
497
18
235
0.76
0.49
1.4
1.5
—
—
—
0
0
20
257
0.77
0.49
2.0
1.6
—
—
—
0
0
43
506
0.84
0.48
1.0
1.1
1.50
1.52
g/l
0.11
43
506
17
220
0.77
0.45
1.6
1.5
122.80
155.78
au/ml
—
5
64
97
878
1.11
0.44
1.5
1.5
—
—
—
0
0
45
386
1.17
0.44
1.7
1.6
33.97
13.55
u/ml
—
6
99
45
522
0.86
0.44
1.1
1.2
0.88
0.91
g/l
0.26
45
522
6
91
0.66
0.42
1.0
1.1
278.67
284.31
mg/l
—
6
80
23
185
1.25
0.42
1.0
1.0
—
—
—
0
0
18
141
1.28
0.40
2.2
2.6
—
—
—
0
0
28
232
1.21
0.40
2.1
2.2
39.97
91.22
ug/min
0.91
19
136
19
237
0.80
0.39
1.1
1.1
0.20
2.07
u/ml
—
10
129
16
124
1.29
0.38
2.4
2.5
0.79
1.47
g/24h
—
7
73
87
791
1.11
0.38
6.1
4.0
1.23
1.23
mmol/l
0.57
80
673
29
243
1.20
0.38
3.6
3.6
54.76
58.04
%
0.70
29
243
132
1227
1.08
0.37
1.6
1.6
—
—
—
0
0
16
200
0.80
0.34
1.1
1.1
0.47
1.72
u/ml
—
8
102
6
45
1.33
0.33
1.5
1.9
0.00
0.07
estimate
—
6
45
16
127
1.26
0.33
1.5
1.4
—
—
nmol/l
—
0
0
43
378
1.14
0.33
4.2
3.3
24.81
24.96
mmol/l
0.12
38
357
14
177
0.79
0.33
1.1
1.1
0.62
2.10
u/ml
—
6
87
13
166
0.78
0.33
1.1
1.1
0.96
3.66
u/ml
—
5
71
10
74
1.35
0.32
12.4
13.1
0.47
0.65
mmol/l
—
10
69
15
119
1.26
0.32
2.1
1.5
10.04
2.62
ug/l
0.50
15
103
57
632
0.90
0.31
1.5
1.7
—
—
—
0
0
21
174
1.21
0.31
1.5
1.2
6.44
5.06
u/ml
—
9
62
14
175
0.80
0.31
2.1
1.9
—
—
—
0
0
23
194
1.19
0.29
3.7
3.8
3.99
4.16
e9/l
0.17
23
194
12
151
0.79
0.28
1.1
1.0
0.22
0.36
u/ml
—
5
52
8
65
1.23
0.27
1.0
1.2
—
—
—
0
0
8
65
1.23
0.27
1.0
1.3
—
—
—
0
0
115
1220
0.94
0.25
1.5
1.4
—
—
—
0
0
9
72
1.25
0.25
1.1
1.0
—
—
—
0
0
88
939
0.93
0.23
1.4
1.4
—
—
—
0
0
5
38
1.32
0.23
1.2
1.1
—
5.18
—
0
9
15
125
1.20
0.22
1.8
1.4
—
—
—
0
0
10
79
1.27
0.22
1.5
1.1
—
—
—
0
0
19
163
1.17
0.21
1.2
1.2
—
—
—
0
0
16
135
1.19
0.21
1.6
2.7
—
—
—
0
0
0
10
0.00
0.21
0.0
13.0
—
0.15
—
0
10
5
43
1.16
0.21
1.0
1.3
7.44
7.37
ph
—
5
31
6
48
1.25
0.20
1.8
1.9
—
—
—
0
0
9
111
0.81
0.20
1.4
1.3
1.60
1.35
nmol/l
—
9
103
15
176
0.85
0.20
3.7
3.4
0.70
0.81
nmol/l
—
9
149
6
50
1.20
0.19
1.0
1.1
161.13
175.41
iu/ml
—
6
50
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
21
235
0.89
0.16
1.2
1.2
243.00
251.97
u/ml
—
10
142
6
76
0.79
0.15
1.2
1.6
—
—
—
0
0
18
159
1.13
0.15
1.1
1.2
—
—
—
0
0
7
88
0.79
0.14
1.0
1.1
—
—
—
0
0
27
246
1.10
0.14
1.2
1.1
—
—
—
0
0
27
246
1.10
0.14
1.2
1.1
—
—
—
0
0
18
202
0.89
0.14
1.6
1.2
—
—
—
0
0
40
373
1.07
0.13
1.3
1.2
—
—
—
0
0
22
202
1.09
0.10
3.8
4.8
1.75
2.46
mmol/l
0.91
17
128
25
268
0.93
0.09
1.7
1.3
—
—
—
0
0
11
97
1.14
0.09
3.8
2.6
—
—
—
0
0
11
97
1.14
0.09
1.3
1.4
—
—
—
0
0
20
185
1.08
0.08
1.4
1.7
1.05
0.75
g/l
0.26
14
148
26
244
1.07
0.08
1.7
1.4
78.88
204.25
pmol/l
1.42
26
239
6
71
0.84
0.07
1.5
1.6
7.08
6.58
mmol/l
—
6
45
7
82
0.85
0.07
1.3
1.3
—
—
—
0
0
13
142
0.91
0.06
1.1
1.1
—
—
—
0
0
12
109
1.10
0.06
1.2
1.3
—
—
—
0
0
30
314
0.95
0.05
1.3
1.2
66.67
97.93
titre
—
6
29
11
120
0.92
0.05
1.1
1.1
—
—
—
0
0
20
189
1.06
0.04
1.1
1.1
—
—
—
0
0
85
839
1.01
0.02
4.2
3.8
—
—
—
0
0
427
4279
1.00
0.01
2.1
2.1
—
—
—
0
0
11
114
0.96
0.00
1.9
2.0
91.24
89.69
%
0.52
11
114
12
116
1.03
0.00
1.3
1.1
—
—
—
0
0
32
316
1.01
0.00
1.3
1.2
—
1174.00
—
0
10
30
302
0.99
0.00
1.1
1.2
—
—
—
0
0
12
121
0.99
0.00
2.4
2.3
—
—
—
0
0
142
1419
1.00
0.00
1.2
1.3
—
—
—
0
0
17
165
1.03
0.00
1.1
1.2
—
—
—
0
0
8
79
1.01
0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.04
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.1
—
104.86
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
402.43
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
54.73
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
4.8
1.2
11.38
24.21
umol/l
—
6
58
0
5
0.00
-0.00
0.0
1.0
—
30.18
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
34.27
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.16
—
0
7
0
9
0.00
-0.00
0.0
1.4
—
460.43
—
0
9
0
7
0.00
-0.00
0.0
1.4
—
390.43
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MONONPOTHUS and mortality.

Females

Parameter HR [95% CI] p-value
G6_MONONPOTHUS 1.214 [1.06, 1.39] 0.004
Birth year 0.999 [0.99, 1.01] 0.8

During the follow-up period (1.1.1998 — 31.12.2019), 397 out of 3043 females with G6_MONONPOTHUS died.

Males

Parameter HR [95% CI] p-value
G6_MONONPOTHUS 1.422 [1.24, 1.63] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 468 out of 3225 males with G6_MONONPOTHUS died.

Mortality risk

Mortality risk for people of age

years, who have G6_MONONPOTHUS.

N-year risk Females Males
1 0.087% 0.276%
5 0.669% 1.607%
10 1.97% 3.865%
15 4.024% 7.496%
20 7.219% 12.516%

Relationships between endpoints

↥

Index endpoint: G6_MONONPOTHUS – Other and unspecified mononeuropathies of upper limb

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data